Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	deaminase binding	HNRNPCL1 HNRNPCL3 HNRNPCL2	3.11e-06	4	185	3	GO:1990827
GeneOntologyMolecularFunction	creatine kinase activity	CKM CKMT2 CKMT1A	1.53e-05	6	185	3	GO:0004111
GeneOntologyMolecularFunction	nuclear receptor activity	RARA RARB ESR1 ESR2 RORB RORC	1.93e-05	60	185	6	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	RARA RARB ESR1 ESR2 RORB RORC	2.12e-05	61	185	6	GO:0098531
GeneOntologyMolecularFunction	phosphotransferase activity, nitrogenous group as acceptor	CKM CKMT2 CKMT1A	4.23e-05	8	185	3	GO:0016775
GeneOntologyMolecularFunction	histidine-tRNA ligase activity	HARS2 HARS1	8.54e-05	2	185	2	GO:0004821
GeneOntologyMolecularFunction	unmethylated CpG binding	KMT2B MBD1 KMT2A	8.95e-05	10	185	3	GO:0045322
GeneOntologyMolecularFunction	transition metal ion binding	CPA6 CYP1B1 CYP2A6 CYP2A7 TUT4 CYP2C8 RARA RARB KMT2B NT5E ESR1 ESR2 CYP24A1 MBD1 CPZ VAT1L UPF1 RPH3A ZRANB3 MEP1A GDA MIB1 KMT2A RORB RORC	1.06e-04	1189	185	25	GO:0046914
GeneOntologyMolecularFunction	chemorepellent activity	SEMA6B SEMA6D SEMA5B FLRT3	1.41e-04	29	185	4	GO:0045499
GeneOntologyMolecularFunction	zinc ion binding	CPA6 TUT4 RARA RARB KMT2B NT5E ESR1 ESR2 MBD1 CPZ VAT1L UPF1 RPH3A ZRANB3 MEP1A GDA MIB1 KMT2A RORB RORC	2.36e-04	891	185	20	GO:0008270
GeneOntologyMolecularFunction	coumarin 7-hydroxylase activity	CYP2A6 CYP2A7	2.55e-04	3	185	2	GO:0008389
GeneOntologyMolecularFunction	steroid hydroxylase activity	CYP1B1 CYP2A6 CYP2A7 CYP2C8	2.66e-04	34	185	4	GO:0008395
GeneOntologyMolecularFunction	aromatase activity	CYP1B1 CYP2A6 CYP2A7 CYP2C8	2.98e-04	35	185	4	GO:0070330
GeneOntologyMolecularFunction	N6-methyladenosine-containing RNA reader activity	HNRNPCL1 HNRNPCL3 HNRNPCL2	3.28e-04	15	185	3	GO:1990247
GeneOntologyMolecularFunction	Wnt receptor activity	FZD1 FZD7 FZD2	4.84e-04	17	185	3	GO:0042813
GeneOntologyMolecularFunction	nuclear estrogen receptor activity	ESR1 ESR2	5.06e-04	4	185	2	GO:0030284
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2B ASH1L KMT2A	7.94e-04	20	185	3	GO:0042800
GeneOntologyMolecularFunction	acyltransferase activity, acyl groups converted into alkyl on transfer	ACLY HMGCS1	8.38e-04	5	185	2	GO:0046912
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	CYP1B1 CYP2A6 CYP2A7 CYP2C8	1.09e-03	49	185	4	GO:0016712
GeneOntologyMolecularFunction	semaphorin receptor binding	SEMA6B SEMA6D SEMA5B	1.21e-03	23	185	3	GO:0030215
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP2A6 CYP2A7 CYP2C8	1.37e-03	24	185	3	GO:0008392
GeneOntologyMolecularFunction	protein-RNA adaptor activity	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.37e-03	24	185	3	GO:0140517
GeneOntologyMolecularFunction	telomerase RNA binding	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.55e-03	25	185	3	GO:0070034
GeneOntologyMolecularFunction	transcription coactivator binding	RARA ESR1 STAT1 RORC	1.57e-03	54	185	4	GO:0001223
GeneOntologyMolecularFunction	ATP-dependent activity	KIF26B UPF1 SMC5 ZRANB3 NUBP2 DHX8 CCT6A ABCA6 KCNJ8 CCT6B DDX23 DNAH5 FIGNL1 DYNC1H1	1.80e-03	614	185	14	GO:0140657
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP2A6 CYP2A7 CYP2C8	1.94e-03	27	185	3	GO:0008391
GeneOntologyMolecularFunction	ligand-gated monoatomic cation channel activity	TRPV1 BEST2 KCNJ6 KCNJ8 KCNMB1 CNGA4	1.96e-03	140	185	6	GO:0099094
GeneOntologyMolecularFunction	kinase activity	PRKD2 OBSCN RIOK3 NOL9 PFKM TRRAP ITPK1 SBK1 CKM CKMT2 PIK3C2A NEK5 PI4KA PPIP5K1 MAPK7 CKMT1A	2.05e-03	764	185	16	GO:0016301
GeneOntologyBiologicalProcess	phosphocreatine metabolic process	CKM CKMT2 CKMT1A	6.45e-06	5	180	3	GO:0006603
GeneOntologyBiologicalProcess	phosphagen biosynthetic process	CKM CKMT2 CKMT1A	6.45e-06	5	180	3	GO:0042396
GeneOntologyBiologicalProcess	phosphagen metabolic process	CKM CKMT2 CKMT1A	6.45e-06	5	180	3	GO:0006599
GeneOntologyBiologicalProcess	phosphocreatine biosynthetic process	CKM CKMT2 CKMT1A	6.45e-06	5	180	3	GO:0046314
GeneOntologyBiologicalProcess	negative regulation of mRNA modification	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.28e-05	6	180	3	GO:0090367
GeneOntologyBiologicalProcess	regulation of mRNA modification	HNRNPCL1 HNRNPCL3 HNRNPCL2	2.23e-05	7	180	3	GO:0090365
GeneOntologyBiologicalProcess	reproductive structure development	CYP1B1 RARA KMT2B ADAM21 ESR1 ESR2 ASH1L RDH10 RLN1 RLN2 CSDE1 SYCP2 RAB13	3.34e-05	383	180	13	GO:0048608
GeneOntologyBiologicalProcess	epoxygenase P450 pathway	CYP1B1 CYP2A6 CYP2A7 CYP2C8	3.63e-05	22	180	4	GO:0019373
GeneOntologyBiologicalProcess	reproductive system development	CYP1B1 RARA KMT2B ADAM21 ESR1 ESR2 ASH1L RDH10 RLN1 RLN2 CSDE1 SYCP2 RAB13	3.82e-05	388	180	13	GO:0061458
GeneOntologyBiologicalProcess	histidyl-tRNA aminoacylation	HARS2 HARS1	7.57e-05	2	180	2	GO:0006427
GeneOntologyBiologicalProcess	retinol metabolic process	CYP1B1 PNPLA2 CYP2C8 RDH10 RDH13	9.79e-05	53	180	5	GO:0042572
GeneOntologyBiologicalProcess	purine nucleoside biosynthetic process	NT5E PGM2 PNP	1.36e-04	12	180	3	GO:0042451
GeneOntologyBiologicalProcess	ribonucleoside biosynthetic process	NT5E PGM2 PNP	1.36e-04	12	180	3	GO:0042455
GeneOntologyBiologicalProcess	purine ribonucleoside biosynthetic process	NT5E PGM2 PNP	1.36e-04	12	180	3	GO:0046129
GeneOntologyBiologicalProcess	prostate gland development	RARA ESR1 ESR2 RLN1 RLN2	2.07e-04	62	180	5	GO:0030850
GeneOntologyCellularComponent	nucleoplasmic periphery of the nuclear pore complex	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.36e-05	6	186	3	GO:1990826
Domain	Znf_hrmn_rcpt	RARA RARB ESR1 ESR2 RORB RORC	5.01e-06	46	180	6	IPR001628
Domain	NUCLEAR_REC_DBD_2	RARA RARB ESR1 ESR2 RORB RORC	5.01e-06	46	180	6	PS51030
Domain	NUCLEAR_REC_DBD_1	RARA RARB ESR1 ESR2 RORB RORC	5.01e-06	46	180	6	PS00031
Domain	ZnF_C4	RARA RARB ESR1 ESR2 RORB RORC	5.01e-06	46	180	6	SM00399
Domain	zf-C4	RARA RARB ESR1 ESR2 RORB RORC	5.01e-06	46	180	6	PF00105
Domain	Nuclear_hrmn_rcpt	RARA RARB ESR1 ESR2 RORB RORC	5.01e-06	46	180	6	IPR001723
Domain	Nucl_hrmn_rcpt_lig-bd	RARA RARB ESR1 ESR2 RORB RORC	6.46e-06	48	180	6	IPR000536
Domain	HOLI	RARA RARB ESR1 ESR2 RORB RORC	6.46e-06	48	180	6	SM00430
Domain	Hormone_recep	RARA RARB ESR1 ESR2 RORB RORC	6.46e-06	48	180	6	PF00104
Domain	hnRNP_C	HNRNPCL1 HNRNPCL4 HNRNPCL2	1.72e-05	6	180	3	IPR017347
Domain	Znf_NHR/GATA	RARA RARB ESR1 ESR2 RORB RORC	1.97e-05	58	180	6	IPR013088
Domain	FRI	CPZ FZD1 FZD7 FZD2	3.58e-05	20	180	4	SM00063
Domain	-	CPZ FZD1 FZD7 FZD2	4.39e-05	21	180	4	1.10.2000.10
Domain	Cyt_P450_E_grp-I	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	7.03e-05	45	180	5	IPR002401
Domain	Frizzled_dom	CPZ FZD1 FZD7 FZD2	7.62e-05	24	180	4	IPR020067
Domain	FZ	CPZ FZD1 FZD7 FZD2	7.62e-05	24	180	4	PS50038
Domain	Fz	CPZ FZD1 FZD7 FZD2	7.62e-05	24	180	4	PF01392
Domain	-	RARA RARB ESR1 ESR2 RORC	8.69e-05	47	180	5	1.10.565.10
Domain	His-tRNA-ligase	HARS2 HARS1	9.24e-05	2	180	2	IPR015807
Domain	Chap_CCT_zeta	CCT6A CCT6B	9.24e-05	2	180	2	IPR012722
Domain	HisRS_anticodon	HARS2 HARS1	9.24e-05	2	180	2	IPR033656
Domain	MeTrfase_trithorax	KMT2B KMT2A	9.24e-05	2	180	2	IPR016569
Domain	HisRS/HisZ	HARS2 HARS1	9.24e-05	2	180	2	IPR004516
Domain	ZF_CXXC	KMT2B MBD1 KMT2A	1.37e-04	11	180	3	PS51058
Domain	Frizzled	FZD1 FZD7 FZD2	1.37e-04	11	180	3	IPR000539
Domain	Frizzled	FZD1 FZD7 FZD2	1.37e-04	11	180	3	PF01534
Domain	Znf_CXXC	KMT2B MBD1 KMT2A	1.37e-04	11	180	3	IPR002857
Domain	zf-CXXC	KMT2B MBD1 KMT2A	1.37e-04	11	180	3	PF02008
Domain	Frizzled	FZD1 FZD7 FZD2	1.37e-04	11	180	3	SM01330
Domain	Cyt_P450_CS	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	1.55e-04	53	180	5	IPR017972
Domain	-	RARA RARB ESR1 ESR2 RORC	2.19e-04	57	180	5	3.30.50.10
Domain	CYTOCHROME_P450	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	2.19e-04	57	180	5	PS00086
Domain	-	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	2.38e-04	58	180	5	1.10.630.10
Domain	p450	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	2.38e-04	58	180	5	PF00067
Domain	ROR_rcpt	RORB RORC	2.75e-04	3	180	2	IPR003079
Domain	Relaxin	RLN1 RLN2	2.75e-04	3	180	2	IPR022421
Domain	BACK	KLHL1 KBTBD6 KBTBD7 GMCL1 GAN	2.80e-04	60	180	5	SM00875
Domain	Cyt_P450	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	2.80e-04	60	180	5	IPR001128
Domain	BACK	KLHL1 KBTBD6 KBTBD7 GMCL1 GAN	3.02e-04	61	180	5	IPR011705
Domain	BACK	KLHL1 KBTBD6 KBTBD7 GMCL1 GAN	3.02e-04	61	180	5	PF07707
Domain	Post-SET_dom	KMT2B ASH1L KMT2A	4.49e-04	16	180	3	IPR003616
Domain	PostSET	KMT2B ASH1L KMT2A	4.49e-04	16	180	3	SM00508
Domain	-	TRRAP PIK3C2A PI4KA	4.49e-04	16	180	3	1.10.1070.11
Domain	PI3Kc	TRRAP PIK3C2A PI4KA	4.49e-04	16	180	3	SM00146
Domain	POST_SET	KMT2B ASH1L KMT2A	4.49e-04	16	180	3	PS50868
Domain	Frizzled/SFRP	FZD1 FZD7 FZD2	4.49e-04	16	180	3	IPR015526
Domain	ATP-gua_PtransN	CKM CKMT2	5.47e-04	4	180	2	PF02807
Domain	Cyt_P450_E_grp-I_CYP2A-like	CYP2A6 CYP2A7	5.47e-04	4	180	2	IPR008067
Domain	PHOSPHAGEN_KINASE	CKM CKMT2	5.47e-04	4	180	2	PS00112
Domain	ATP-gua_Ptrans	CKM CKMT2	5.47e-04	4	180	2	PF00217
Domain	A-D-PHexomutase_CS	PGM3 PGM2	5.47e-04	4	180	2	IPR016066
Domain	Mib_Herc2	MIB1 HECTD1	5.47e-04	4	180	2	IPR010606
Domain	Retinoic_acid_rcpt	RARA RARB	5.47e-04	4	180	2	IPR003078
Domain	-	CKM CKMT2	5.47e-04	4	180	2	1.10.135.10
Domain	MIB_HERC2	MIB1 HECTD1	5.47e-04	4	180	2	PS51416
Domain	MIB_HERC2	MIB1 HECTD1	5.47e-04	4	180	2	PF06701
Domain	ATP-guanido_PTrfase_N	CKM CKMT2	5.47e-04	4	180	2	IPR022413
Domain	ATP-guanido_PTrfase_AS	CKM CKMT2	5.47e-04	4	180	2	IPR022415
Domain	ATP-guanido_PTrfase_cat	CKM CKMT2	5.47e-04	4	180	2	IPR022414
Domain	PHOSPHAGEN_KINASE_N	CKM CKMT2	5.47e-04	4	180	2	PS51509
Domain	PHOSPHAGEN_KINASE_C	CKM CKMT2	5.47e-04	4	180	2	PS51510
Domain	P-loop_NTPase	KIF26B UPF1 HNRNPUL1 SMC5 ZRANB3 NUBP2 DHX8 NWD2 ABCA6 EIF2S3 DDX23 DLG3 GNAI3 MYO18B DNAH5 FIGNL1 RAB13 DYNC1H1 AGAP2	5.55e-04	848	180	19	IPR027417
Domain	PI3_PI4_kinase	TRRAP PIK3C2A PI4KA	6.46e-04	18	180	3	PF00454
Domain	PI3_4_KINASE_1	TRRAP PIK3C2A PI4KA	6.46e-04	18	180	3	PS00915
Domain	PI3_4_KINASE_2	TRRAP PIK3C2A PI4KA	6.46e-04	18	180	3	PS00916
Domain	PI3/4_kinase_cat_dom	TRRAP PIK3C2A PI4KA	6.46e-04	18	180	3	IPR000403
Domain	PI3_4_KINASE_3	TRRAP PIK3C2A PI4KA	6.46e-04	18	180	3	PS50290
Domain	Semaphorin	SEMA6B SEMA6D SEMA5B	8.89e-04	20	180	3	IPR027231
Domain	FYrich_C	KMT2B KMT2A	9.06e-04	5	180	2	IPR003889
Domain	FYrich_N	KMT2B KMT2A	9.06e-04	5	180	2	IPR003888
Domain	FYRC	KMT2B KMT2A	9.06e-04	5	180	2	SM00542
Domain	FYRN	KMT2B KMT2A	9.06e-04	5	180	2	SM00541
Domain	VWA_N	CACNA2D1 CACHD1	9.06e-04	5	180	2	IPR013608
Domain	PGM_PMM	PGM3 PGM2	9.06e-04	5	180	2	PS00710
Domain	ATP-guanido_PTrfase	CKM CKMT2	9.06e-04	5	180	2	IPR000749
Domain	PGM_PMM_II	PGM3 PGM2	9.06e-04	5	180	2	PF02879
Domain	PGM_PMM_I	PGM3 PGM2	9.06e-04	5	180	2	PF02878
Domain	VWA_N	CACNA2D1 CACHD1	9.06e-04	5	180	2	PF08399
Domain	PGM_PMM_IV	PGM3 PGM2	9.06e-04	5	180	2	PF00408
Domain	-	PGM3 PGM2	9.06e-04	5	180	2	3.40.120.10
Domain	A-D-PHexomutase_a/b/a-I/II/III	PGM3 PGM2	9.06e-04	5	180	2	IPR016055
Domain	Oest_rcpt/oest-rel_rcp	ESR1 ESR2	9.06e-04	5	180	2	IPR024178
Domain	A-D-PHexomutase_a/b/a-I	PGM3 PGM2	9.06e-04	5	180	2	IPR005844
Domain	A-D-PHexomutase_a/b/a-II	PGM3 PGM2	9.06e-04	5	180	2	IPR005845
Domain	A-D-PHexomutase_C	PGM3 PGM2	9.06e-04	5	180	2	IPR005843
Domain	Alpha-D-phosphohexomutase_SF	PGM3 PGM2	9.06e-04	5	180	2	IPR005841
Domain	-	PGM3 PGM2	9.06e-04	5	180	2	3.30.310.50
Domain	FYRN	KMT2B KMT2A	9.06e-04	5	180	2	PF05964
Domain	FYRC	KMT2B KMT2A	9.06e-04	5	180	2	PF05965
Domain	FYRC	KMT2B KMT2A	9.06e-04	5	180	2	PS51543
Domain	FYRN	KMT2B KMT2A	9.06e-04	5	180	2	PS51542
Domain	Mab-21-like_1/2	MAB21L2 MAB21L1	9.06e-04	5	180	2	IPR020950
Domain	-	UPF1 HNRNPUL1 SMC5 ZRANB3 NUBP2 DHX8 NWD2 ABCA6 EIF2S3 DDX23 DLG3 GNAI3 DNAH5 FIGNL1 RAB13 DYNC1H1 AGAP2	9.08e-04	746	180	17	3.40.50.300
Domain	Gln_synth/guanido_kin_cat_dom	CKM CKMT2	1.35e-03	6	180	2	IPR014746
Domain	Insulin_family	RLN1 RLN2	1.35e-03	6	180	2	IPR022352
Domain	GDNF	GAS1 GFRA2	1.35e-03	6	180	2	PF02351
Domain	GDNF	GAS1 GFRA2	1.35e-03	6	180	2	SM00907
Domain	GDNF/GAS1	GAS1 GFRA2	1.35e-03	6	180	2	IPR016017
Domain	-	CKM CKMT2	1.35e-03	6	180	2	3.30.590.10
Domain	BTB	KLHL1 KBTBD6 KBTBD7 GMCL1 GMCL2 GAN	1.70e-03	131	180	6	PF00651
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	RARA RARB ESR1 ESR2 RORB RORC	8.14e-06	48	142	6	MM14987
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	RARA RARB ESR1 ESR2 RORB RORC	1.46e-05	53	142	6	M8276
Pathway	KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY	CKM CKMT2 CKMT1A	3.40e-05	7	142	3	M47940
Pathway	WP_NUCLEAR_RECEPTORS	RARA RARB ESR1 ESR2 RORC	3.71e-05	38	142	5	M39657
Pathway	WP_NUCLEAR_RECEPTORS	RARA RARB ESR1 ESR2 RORC	3.71e-05	38	142	5	MM15865
Pathway	REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	FBXW10 ARFGEF2 FBXL3 CCT6A CCT6B	4.22e-05	39	142	5	M3871
Pathway	REACTOME_RHOBTB2_GTPASE_CYCLE	HNRNPCL1 HNRNPCL3 CCT6A HNRNPCL2	1.06e-04	25	142	4	MM15606
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2C8	1.56e-04	11	142	3	M27130
Pathway	REACTOME_CREATINE_METABOLISM	CKM CKMT2 CKMT1A	1.56e-04	11	142	3	M27681
Pathway	REACTOME_CREATINE_METABOLISM	CKM CKMT2 CKMT1A	1.56e-04	11	142	3	MM15402
Pathway	REACTOME_CYP2E1_REACTIONS	CYP2A6 CYP2A7 CYP2C8	2.06e-04	12	142	3	MM14847
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	PNPLA2 ADAMTSL1 FBXW10 HNRNPCL1 FBXL13 RARA THSD7A ESR1 MBD1 MUC5B SMC5 TRRAP KBTBD7 FBXL3 PGM3 HNRNPCL3 GALNT17 SEMA5B ATXN7 CTR9 ASB7 TRAPPC6B GAN RAB13 DYNC1H1 TTLL13 HNRNPCL2 PCSK9	2.67e-04	1389	142	28	MM15307
Pathway	KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4	FZD1 FZD7 FZD2	3.36e-04	14	142	3	M47834
Pathway	WP_OXIDATION_BY_CYTOCHROME_P450	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	3.94e-04	62	142	5	M39653
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	4.57e-04	64	142	5	M5650
Pathway	KEGG_RETINOL_METABOLISM	CYP2A6 CYP2A7 CYP2C8 RDH10 UGT2A3	4.57e-04	64	142	5	M9488
Pathway	REACTOME_RHOBTB_GTPASE_CYCLE	HNRNPCL1 HNRNPCL3 CCT6A HNRNPCL2	5.03e-04	37	142	4	MM15683
Pathway	KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY	FZD1 FZD7 FZD2	5.09e-04	16	142	3	M47823
Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1	5.27e-04	66	142	5	MM14839
Pathway	REACTOME_PURINE_CATABOLISM	NT5E GDA PNP	6.14e-04	17	142	3	M842
Pathway	REACTOME_PURINE_CATABOLISM	NT5E GDA PNP	7.31e-04	18	142	3	MM15439
Pubmed	Oxytocin and estrogen receptor expression in the myometrium of pregnant relaxin-deficient (Rlx-/-) mice.	ESR1 ESR2 RLN1 RLN2	1.23e-08	6	188	4	15956692
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	ACLY EIF2S3B RDH13 UPF1 NOL9 HNRNPUL1 PFKM FBXL3 STAT1 NUBP2 PGM3 CSDE1 WDR3 CCT6A CTR9 EIF2S3 EXO1 CCT6B DDX23 GNAI3 SLC25A19 HECTD1 DYNC1H1 PNP CKMT1A	2.19e-08	1257	188	25	37317656
Pubmed	Molecular cloning, differential expression, and chromosomal localization of human frizzled-1, frizzled-2, and frizzled-7.	FZD1 FZD7 FZD2	1.55e-07	3	188	3	9813155
Pubmed	Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease.	CYP1B1 ESR1 ESR2	1.55e-07	3	188	3	16808847
Pubmed	Frizzled proteins are colonic epithelial receptors for C. difficile toxin B.	FZD1 FZD7 FZD2	1.55e-07	3	188	3	27680706
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	FKBP10 CACNA2D1 SPR ACLY RDH13 ITGA3 HNRNPUL1 PFKM TRRAP STAT1 CSDE1 WDR3 CKM CCT6A GDA EIF2S3 GNAI3 HARS1 HECTD1 TOP3B PGM2 RAB13 DYNC1H1 PNP	1.62e-07	1297	188	24	33545068
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	HNRNPCL1 ACLY EIF2S3B PFKM TRRAP RPH3A ADD2 HNRNPCL3 CCT6A GDA EIF2S3 CCT6B GNAI3 DYNC1H1 HNRNPCL2 CKMT1A	3.14e-07	621	188	16	22794259
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CYP1B1 KMT2B NT5E ESR1 MBD1 RDH13 NOL9 TRRAP STAT1 DHX8 CSDE1 WDR3 CCT6A HARS2 PIK3C2A ATXN7 CTR9 RBM19 EIF2S3 PI4KA LRCH4 KMT2A DLG3 ZC3H7B CKMT1A	5.89e-07	1497	188	25	31527615
Pubmed	hnRNPC induces isoform shifts in miR-21-5p leading to cancer development.	HNRNPCL1 HNRNPCL3 HNRNPCL2	6.19e-07	4	188	3	35729324
Pubmed	N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.	HNRNPCL1 HNRNPCL3 HNRNPCL2	6.19e-07	4	188	3	36681355
Pubmed	hnRNP C is required for postimplantation mouse development but Is dispensable for cell viability.	HNRNPCL1 HNRNPCL3 HNRNPCL2	6.19e-07	4	188	3	10805751
Pubmed	ERα regulates lipid metabolism in bone through ATGL and perilipin.	PNPLA2 ESR1 ESR2	6.19e-07	4	188	3	23296636
Pubmed	Expression of P2X3 and TRPV1 receptors in primary sensory neurons from estrogen receptors-α and estrogen receptor-β knockout mice.	TRPV1 ESR1 ESR2	6.19e-07	4	188	3	22581043
Pubmed	The splicing factor hnRNP C regulates expression of co-stimulatory molecules CD80 and CD40 in dendritic cells.	HNRNPCL1 HNRNPCL3 HNRNPCL2	6.19e-07	4	188	3	23831410
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RARA KMT2B SPR ACLY HMGCS1 UPF1 HNRNPUL1 PFKM TRRAP STAT1 ARL6IP4 CSDE1 CCT6A TNRC18 CTR9 EIF2S3 DDX23 KMT2A DYNC1H1 PNP MYBL2	6.48e-07	1103	188	21	34189442
Pubmed	Automated yeast two-hybrid screening for nuclear receptor-interacting proteins.	RARA RARB ESR1 ESR2 SAT2 RORB RORC HARS1	6.91e-07	133	188	8	15604093
Pubmed	PTEN identified as important risk factor of chronic obstructive pulmonary disease.	CYP1B1 ESR1 ESR2 CYP24A1 SAT2 STAT1 NUBP2 FZD7 IGFBP2 ABCA6 EXO1 MYBL2	1.05e-06	374	188	12	19625176
Pubmed	Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway.	CYP1B1 ESR1 ESR2 CYP24A1 SAT2 STAT1 NUBP2 FZD7 IGFBP2 ABCA6 EXO1 MYBL2	1.27e-06	381	188	12	18676680
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SPR ACLY RIOK3 UPF1 NOL9 HNRNPUL1 PFKM TRRAP STAT1 CSDE1 WDR3 CCT6A PCGF6 PIK3C2A CTR9 RBM19 PI4KA MIB1 CCT6B DDX23 RAB13 DYNC1H1 PNP	1.29e-06	1353	188	23	29467282
Pubmed	Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.	CYP1B1 ESR1 ESR2 CYP24A1 SAT2 STAT1 NUBP2 FZD7 IGFBP2 ABCA6 EXO1 MYBL2	1.31e-06	382	188	12	19170196
Pubmed	Heterogeneous nuclear ribonucleoprotein C1 may control miR-30d levels in endometrial exosomes affecting early embryo implantation.	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.54e-06	5	188	3	29846695
Pubmed	Evaluating the role of hnRNP-C and FMRP in the cAMP-induced APP metabolism.	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.54e-06	5	188	3	25809670
Pubmed	Isolation and characterization of the gene and cDNA encoding human mitochondrial creatine kinase.	CKM CKMT2 CKMT1A	1.54e-06	5	188	3	2914937
Pubmed	Characterization of two nuclear proteins that interact with cytochrome P-450 1A2 mRNA. Regulation of RNA binding and possible role in the expression of the Cyp1a2 gene.	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.54e-06	5	188	3	9128719
Pubmed	Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).	RARA ESR1 ESR2	1.54e-06	5	188	3	9773978
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PRKD2 RARB MBD1 ASH1L APBB2 ARFGEF2 CACHD1 HNRNPUL1 RPH3A STAT1 PLEKHH1 CSDE1 WDR3 GMCL1 CTR9 KCNJ6 MIB1 RORB HARS1 HECTD1 DYNC1H1 AGAP2	1.99e-06	1285	188	22	35914814
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6B PRKD2 PNPLA2 KMT2B RDH10 OBSCN ARFGEF2 ITGA3 TRRAP FZD1 FZD7 TNRC18 MTMR14 RBM19 PI4KA ZC3H7B HECTD1 TOP3B DYNC1H1 MYBL2	2.62e-06	1105	188	20	35748872
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	PRKD2 TUT4 ARFGEF2 HNRNPUL1 NUBP2 CSDE1 CCT6A CD163L1 EIF2S3 DLG3 GNAI3 CKMT1A	2.78e-06	411	188	12	36652389
Pubmed	Opposite Dysregulation of Fragile-X Mental Retardation Protein and Heteronuclear Ribonucleoprotein C Protein Associates with Enhanced APP Translation in Alzheimer Disease.	HNRNPCL1 HNRNPCL3 HNRNPCL2	3.07e-06	6	188	3	26048669
Pubmed	ERAP140, a conserved tissue-specific nuclear receptor coactivator.	RARA ESR1 ESR2	3.07e-06	6	188	3	11971969
Pubmed	Protein kinase CK1alpha regulates mRNA binding by heterogeneous nuclear ribonucleoprotein C in response to physiologic levels of hydrogen peroxide.	HNRNPCL1 HNRNPCL3 HNRNPCL2	3.07e-06	6	188	3	15687492
Pubmed	Concomitant transitory up-regulation of X-linked inhibitor of apoptosis protein (XIAP) and the heterogeneous nuclear ribonucleoprotein C1-C2 in surviving cells during neuronal apoptosis.	HNRNPCL1 HNRNPCL3 HNRNPCL2	3.07e-06	6	188	3	18363099
Pubmed	The human homologue of the yeast DNA repair and TFIIH regulator MMS19 is an AF-1-specific coactivator of estrogen receptor.	RARA ESR1 ESR2	3.07e-06	6	188	3	11279242
Pubmed	FZD2 regulates limb development by mediating β-catenin-dependent and -independent Wnt signaling pathways.	FZD1 FZD7 FZD2	3.07e-06	6	188	3	36867021
Pubmed	Selective disruption of genes expressed in totipotent embryonal stem cells.	HNRNPCL1 HNRNPCL3 HNRNPCL2	3.07e-06	6	188	3	1317320
Pubmed	Inhibition of oxytocin receptor and estrogen receptor-alpha expression, but not relaxin receptors (LGR7), in the myometrium of late pregnant relaxin gene knockout mice.	ESR1 RLN1 RLN2	3.07e-06	6	188	3	12959965
Pubmed	Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women.	CYP1B1 ESR1 ESR2	3.07e-06	6	188	3	19630952
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CACNA2D1 HNRNPCL1 ACLY TTC21A ARFGEF2 EIF2S3B UPF1 PFKM RPH3A ADD2 HNRNPCL3 CSDE1 CCT6A GDA NWD2 EIF2S3 PI4KA KMT2A DLG3 DYNC1H1 HNRNPCL2 AGAP2 CKMT1A	3.28e-06	1431	188	23	37142655
Pubmed	Genetic susceptibility to distinct bladder cancer subphenotypes.	CYP1B1 ESR1 ESR2 CYP24A1 SAT2 STAT1 NUBP2 FZD7 IGFBP2 ABCA6 EXO1 MYBL2	3.55e-06	421	188	12	19692168
Pubmed	Molecular genetics of the human cytochrome P450 monooxygenase superfamily.	CYP1B1 CYP2A6 CYP2A7 CYP2C8	3.74e-06	20	188	4	9890157
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	PRKD2 HNRNPCL1 ACLY EIF2S3B UPF1 HNRNPUL1 DHX8 HNRNPCL3 CSDE1 WDR3 CCT6A EIF2S3 DDX23 HNRNPCL4 GNAI3 RAB13 DYNC1H1 HNRNPCL2	4.51e-06	949	188	18	36574265
Pubmed	The ATG5 interactome links clathrin-mediated vesicular trafficking with the autophagosome assembly machinery.	APBB2 HNRNPUL1 NUBP2 CCT6A PIK3C2A PI4KA TRAPPC6B TOP3B RAB13	4.94e-06	230	188	9	35449600
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	CACHD1 HNRNPUL1 LPIN1 CCT6A PIK3C2A RBM19 HECTD1 DYNC1H1 WDR62	5.30e-06	232	188	9	25515538
Pubmed	[LOH and genetic polymorphysms of breast cancer].	CYP1B1 ESR1 ESR2	5.35e-06	7	188	3	23350368
Pubmed	The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function.	RARA ESR1 ESR2	5.35e-06	7	188	3	9192892
Pubmed	Creatine and creatinine metabolism.	CKM CKMT2 CKMT1A	5.35e-06	7	188	3	10893433
Pubmed	The structure of the nuclear hormone receptors.	RARB ESR1 ESR2	5.35e-06	7	188	3	10406480
Pubmed	Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR.	RARA ESR1 ESR2	5.35e-06	7	188	3	10788465
Pubmed	Creatine kinase (CK) in skeletal muscle energy metabolism: a study of mouse mutants with graded reduction in muscle CK expression.	RARA RARB CKM	5.35e-06	7	188	3	8090775
Pubmed	Age-related expression analysis of mouse liver nuclear protein binding to 3'-untranslated region of Period2 gene.	HNRNPCL1 HNRNPCL3 HNRNPCL2	5.35e-06	7	188	3	25846207
Pubmed	Vti1b promotes TRPV1 sensitization during inflammatory pain.	TRPV1 ACLY EIF2S3B PFKM ADD2 CSDE1 EIF2S3	6.24e-06	127	188	7	30335684
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2B ASH1L KMT2A	8.53e-06	8	188	3	23130995
Pubmed	Sequence requirement and subtype specificity in the high-affinity interaction between human frizzled and dishevelled proteins.	FZD1 FZD7 FZD2	8.53e-06	8	188	3	19388021
Pubmed	Modulator recognition factor 1, an AT-rich interaction domain family member, is a novel corepressor for estrogen receptor alpha.	RARA ESR1 ESR2	8.53e-06	8	188	3	15941852
Pubmed	RNomics: an experimental approach that identifies 201 candidates for novel, small, non-messenger RNAs in mouse.	HNRNPCL1 PFKM ADD2 HNRNPCL3 CCT6A HNRNPCL2	8.64e-06	88	188	6	11387227
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	MXRA5 APBB2 TRRAP PGM3 CCT6A SEMA5B CCT6B GAN	8.78e-06	187	188	8	26460568
Pubmed	Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells.	HNRNPCL1 HNRNPCL3 ZC3H7B HNRNPCL2	1.13e-05	26	188	4	15890332
Pubmed	Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly.	NT5E ACLY ITGA3 CCT6A GNAI3 DYNC1H1	1.19e-05	93	188	6	38245532
Pubmed	Signaling through retinoic acid receptors is essential for mammalian uterine receptivity and decidualization.	RARA RARB ESR1 ESR2 ADD2	1.22e-05	55	188	5	34292881
Pubmed	Small subfamily of olfactory receptor genes: structural features, expression pattern and genomic organization.	HNRNPCL1 HNRNPCL3 HNRNPCL2	1.27e-05	9	188	3	10452948
Pubmed	Direct interaction of Frizzled-1, -2, -4, and -7 with PDZ domains of PSD-95.	FZD1 FZD7 FZD2	1.27e-05	9	188	3	12067714
Pubmed	Frizzled 2 and frizzled 7 function redundantly in convergent extension and closure of the ventricular septum and palate: evidence for a network of interacting genes.	FZD1 FZD7 FZD2	1.27e-05	9	188	3	23095888
Pubmed	Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect.	CYP1B1 ESR1 ESR2	1.27e-05	9	188	3	18980759
Pubmed	A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals.	FZD1 FZD7 FZD2	1.27e-05	9	188	3	9707618
Pubmed	Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.	ESR1 ESR2 TRRAP	1.81e-05	10	188	3	12738788
Pubmed	Impairing retinoic acid signalling in the neural crest cells is sufficient to alter entire eye morphogenesis.	RARA RARB GAS1	1.81e-05	10	188	3	18539269
Pubmed	Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo.	CYP1B1 ESR1 ESR2	1.81e-05	10	188	3	18794456
Pubmed	DNA Sequence Recognition of Human CXXC Domains and Their Structural Determinants.	KMT2B MBD1 KMT2A	1.81e-05	10	188	3	29276034
Pubmed	Expression of Frizzled genes in developing and postnatal hair follicles.	FZD1 FZD7 FZD2	1.81e-05	10	188	3	15245425
Pubmed	Essential roles of mesenchyme-derived beta-catenin in mouse Müllerian duct morphogenesis.	FZD1 FZD7 FZD2	1.81e-05	10	188	3	17532316
Pubmed	The core component of the mammalian SWI/SNF complex SMARCD3/BAF60c is a coactivator for the nuclear retinoic acid receptor.	RARA RARB ESR1	1.81e-05	10	188	3	17363140
Pubmed	Expression of Frizzled5, Frizzled7, and Frizzled10 during early mouse development and interactions with canonical Wnt signaling.	FZD1 FZD7 FZD2	2.48e-05	11	188	3	17576136
Pubmed	Distinct but redundant expression of the Frizzled Wnt receptor genes at signaling centers of the developing mouse brain.	FZD1 FZD7 FZD2	2.48e-05	11	188	3	17582687
Pubmed	Frizzled-9 impairs acetylcholine receptor clustering in skeletal muscle cells.	FZD1 FZD7 FZD2	2.48e-05	11	188	3	24860427
Pubmed	Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.	CYP1B1 ESR1 ESR2	2.48e-05	11	188	3	19776291
Pubmed	Molecular determinants of WNT9b responsiveness in nephron progenitor cells.	FZD1 FZD7 FZD2	2.48e-05	11	188	3	30978219
Pubmed	Deciphering the role of retinoic acid in hepatic patterning and induction in the mouse.	RARA RARB RDH10	2.48e-05	11	188	3	36028102
Pubmed	Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.	ESR1 ESR2	2.91e-05	2	188	2	29655286
Pubmed	Alleles and haplotypes of the estrogen receptor alpha gene are associated with an increased risk of spontaneous abortion.	ESR1 ESR2	2.91e-05	2	188	2	19200973
Pubmed	Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.	ESR1 ESR2	2.91e-05	2	188	2	11826769
Pubmed	Characterization of a novel CYP2A7/CYP2A6 hybrid allele (CYP2A6*12) that causes reduced CYP2A6 activity.	CYP2A6 CYP2A7	2.91e-05	2	188	2	12325023
Pubmed	Ablation of estrogen receptor alpha or beta eliminates sex differences in mechanical pain threshold in normal and inflamed mice.	ESR1 ESR2	2.91e-05	2	188	2	19285805
Pubmed	Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse.	ESR1 ESR2	2.91e-05	2	188	2	22038234
Pubmed	Tamoxifen induces hypercoagulation and alterations in ERα and ERβ dependent on breast cancer sub-phenotype ex vivo.	ESR1 ESR2	2.91e-05	2	188	2	33159119
Pubmed	Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells.	ESR1 ESR2	2.91e-05	2	188	2	16118406
Pubmed	Expression of aromatase and estrogen receptors in lumbar motoneurons of mice.	ESR1 ESR2	2.91e-05	2	188	2	28501695
Pubmed	Estradiol-induced proliferation of papillary and follicular thyroid cancer cells is mediated by estrogen receptors alpha and beta.	ESR1 ESR2	2.91e-05	2	188	2	20372779
Pubmed	The distribution of cells containing estrogen receptor-alpha (ERalpha) and ERbeta messenger ribonucleic acid in the preoptic area and hypothalamus of the sheep: comparison of males and females.	ESR1 ESR2	2.91e-05	2	188	2	10919284
Pubmed	Estrogen Receptor Expression in Pancreatic Adenocarcinoma: Time to Reconsider Evidence.	ESR1 ESR2	2.91e-05	2	188	2	34860807
Pubmed	Estrogen receptor alpha and beta polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy?	ESR1 ESR2	2.91e-05	2	188	2	16735942
Pubmed	Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours.	ESR1 ESR2	2.91e-05	2	188	2	16880783
Pubmed	Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.	ESR1 ESR2	2.91e-05	2	188	2	17889406
Pubmed	Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.	ESR1 ESR2	2.91e-05	2	188	2	17924141
Pubmed	Pregnancy and oestrogen regulate sinoatrial node calcium homeostasis and accelerate pacemaking.	ESR1 ESR2	2.91e-05	2	188	2	29800268
Pubmed	The differential fate of mesonephric tubular-derived efferent ductules in estrogen receptor-alpha knockout versus wild-type female mice.	ESR1 ESR2	2.91e-05	2	188	2	11014235
Pubmed	17Beta-estradiol regulation of the mRNA expression of T-type calcium channel subunits: role of estrogen receptor alpha and estrogen receptor beta.	ESR1 ESR2	2.91e-05	2	188	2	19003958
Pubmed	Variants in estrogen receptor alpha gene are associated with phenotypical expression of obsessive-compulsive disorder.	ESR1 ESR2	2.91e-05	2	188	2	20850223
Pubmed	Effects of estrogen on the vascular injury response in estrogen receptor alpha, beta (double) knockout mice.	ESR1 ESR2	2.91e-05	2	188	2	11557741
Pubmed	Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism.	ESR1 ESR2	2.91e-05	2	188	2	12952206
Pubmed	Long-Term Neonatal Estrogen Exposure Causes Irreversible Inhibition of LH Pulses by Suppressing Arcuate Kisspeptin Expression via Estrogen Receptors α and β in Female Rodents.	ESR1 ESR2	2.91e-05	2	188	2	28368450
Interaction	PLXNA4 interactions	SEMA6B HNRNPCL1 HNRNPCL3 SEMA6D SEMA5B HNRNPCL2	1.54e-07	28	181	6	int:PLXNA4
Interaction	PLXNA2 interactions	SEMA6B HNRNPCL1 ADAM21 HNRNPCL3 RLN1 SEMA6D SEMA5B HNRNPCL2	1.93e-06	93	181	8	int:PLXNA2
Interaction	NCOA6 interactions	RARA KMT2B ESR1 ESR2 SMC5 KMT2A RORB RORC TOP3B	6.62e-06	145	181	9	int:NCOA6
Interaction	KARS1 interactions	ACLY ESR1 ESR2 HMGCS1 MAB21L2 STAT1 OVOL2 CSDE1 CCT6A HARS2 ALDH16A1 HARS1 HECTD1 TOP3B	9.95e-06	383	181	14	int:KARS1
Interaction	AGAP3 interactions	ESR1 ESR2 UPF1 KBTBD7 STAT1 TOP3B HNRNPCL2	1.06e-05	84	181	7	int:AGAP3
Interaction	ZC3H11A interactions	HNRNPCL1 ESR1 ESR2 SMC5 KBTBD7 DHX8 HECTD1 FIGNL1 TOP3B HNRNPCL2	2.56e-05	215	181	10	int:ZC3H11A
Interaction	MAP1LC3B interactions	KBTBD6 ACLY UPF1 HNRNPUL1 PFKM KBTBD7 STAT1 WDR3 CCT6A MTMR14 CTR9 ZC3H7B HECTD1 PGM2 RAB13 MYBL2	3.94e-05	551	181	16	int:MAP1LC3B
Interaction	TADA3 interactions	RARA KMT2B ESR1 ESR2 SMC5 TRRAP ATXN7 KMT2A	4.16e-05	141	181	8	int:TADA3
Interaction	ZFC3H1 interactions	HNRNPCL1 ESR1 ESR2 UPF1 DHX8 MIB1 GAN HECTD1 DYNC1H1	4.62e-05	185	181	9	int:ZFC3H1
Interaction	AZU1 interactions	KBTBD6 SH3GL2 KBTBD7 FIGNL1	4.88e-05	23	181	4	int:AZU1
Interaction	HNRNPCL3 interactions	HNRNPCL1 SMC5 HNRNPCL3 HNRNPCL2	4.88e-05	23	181	4	int:HNRNPCL3
Interaction	KDM5A interactions	RARA ESR1 ESR2 CCT6A KMT2A HNRNPCL2	5.39e-05	74	181	6	int:KDM5A
Interaction	ATG5 interactions	ESR2 APBB2 HNRNPUL1 STAT1 NUBP2 CCT6A PIK3C2A PI4KA TRAPPC6B GAN TOP3B RAB13	6.82e-05	344	181	12	int:ATG5
Interaction	BYSL interactions	TSR2 ESR1 ESR2 RIOK3 SMC5 TRRAP WDR3 GMCL1 CCT6A RBM19 HECTD1 TOP3B	7.21e-05	346	181	12	int:BYSL
Interaction	AFF4 interactions	ESR1 SMC5 DHX8 ARL6IP4 CTR9 DDX23 KMT2A	8.13e-05	115	181	7	int:AFF4
Interaction	CDX1 interactions	KBTBD6 ASH1L UPF1 KBTBD7 DHX8 RBM19	8.37e-05	80	181	6	int:CDX1
Interaction	CKMT1A interactions	ESR1 ESR2 SMC5 CKM CKMT2 CKMT1A	8.97e-05	81	181	6	int:CKMT1A
Interaction	TAF9 interactions	ESR1 ESR2 SMC5 TRRAP DHX8 ATXN7 KMT2A HNRNPCL2	9.70e-05	159	181	8	int:TAF9
Interaction	RBM6 interactions	ESR1 ESR2 SMC5 TRRAP DHX8 DDX23 HECTD1	1.01e-04	119	181	7	int:RBM6
Interaction	ZC3H7B interactions	ESR1 ZC3H7B HECTD1 TOP3B HNRNPCL2	1.02e-04	52	181	5	int:ZC3H7B
Interaction	ATAD5 interactions	ESR1 ESR2 SMC5 MIB1 HECTD1 HNRNPCL2	1.10e-04	84	181	6	int:ATAD5
Interaction	ACTRT2 interactions	CCT6A CCT6B SLC25A19	1.11e-04	11	181	3	int:ACTRT2
GeneFamily	Nuclear hormone receptors	RARA RARB ESR1 ESR2 RORB RORC	1.89e-06	49	138	6	71
GeneFamily	G protein-coupled receptors, Class F frizzled	FZD1 FZD7 FZD2	6.86e-05	11	138	3	286
GeneFamily	Zinc fingers CXXC-type	KMT2B MBD1 KMT2A	9.10e-05	12	138	3	136
GeneFamily	Immunoglobulin like domain containing\|Semaphorins	SEMA6B SEMA6D SEMA5B	4.51e-04	20	138	3	736
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2B ASH1L KMT2A	2.19e-03	34	138	3	487
GeneFamily	Cytochrome P450 family 2	CYP2A6 CYP2A7 CYP2C8	2.38e-03	35	138	3	1001
Coexpression	GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP	PRKD2 SLC26A1 PLEKHH1 CKM SEMA5B PIK3C2A EXO1 DLG3 SLC25A19 MYBL2	1.70e-06	199	186	10	M8538
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSR2 KLHL1 RDH10 NEK5 RORC HARS1 MAPK7 FIGNL1 TOP3B	1.14e-08	145	187	9	186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CPA6 TRPV1 ESR2 OBSCN MAB21L2 VILL MAB21L1	1.84e-08	70	187	7	8d6bdf2e773e894a0db39fdff1fafc2474e03fcf
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 MYOT OBSCN FHOD3 CD163 CKMT2 GALNT17 MYO18B	6.32e-07	170	187	8	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT OBSCN FHOD3 PFKM CKM CKMT2 MYO18B PCSK9	8.57e-07	177	187	8	692cd03bf0958ebeec34d41bfe87713a768e9a8e
ToppCell	facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT OBSCN FHOD3 PFKM CKM CKMT2 MYO18B PCSK9	8.57e-07	177	187	8	c08583ea68bbeb6b5de852a46b0c0f04792dae55
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CPA6 TRPV1 ESR2 OBSCN VILL CD163L1	8.83e-07	77	187	6	a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA2D1 FBXW10 THSD7A VARS2 FZD1 IGFBP2 FASTKD3 FZD2	1.10e-06	183	187	8	dc9602bed3136db91faeffef177006246dc92743
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A GAS1 ITGA3 CR1 IGFBP2 MIB1 FLRT3 FZD2	1.30e-06	187	187	8	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ADAMTSL1 NT5E TTC21A CACHD1 VAT1L FZD1 FLRT3	1.31e-06	130	187	7	8bd038b0423960ffdc6c8b128c46a55386f9c58c
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VAT1L RPH3A GFRA2 ADD2 CARTPT NWD2 KCNJ6 MAB21L1	1.35e-06	188	187	8	bd091503f580dedab40e0996273101285d24b586
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A GAS1 ITGA3 CR1 IGFBP2 MIB1 FLRT3 FZD2	1.64e-06	193	187	8	3eaa0461618582a1754400624350d269d24e750a
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 ADAMTSL1 RARB THSD7A NT5E VAT1L OVOL2	1.77e-06	195	187	8	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CYP1B1 NT5E SBK1 LPIN1 ATXN7 CD163L1 FLRT3	1.87e-06	137	187	7	b553958e7e6dcd887d860e34d3983cbb85cefaa6
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP24A1 OBSCN FHOD3 CACHD1 ITGA3 FAT2 IGFBP2 FLRT3	2.06e-06	199	187	8	94a7867e800df352731796de8c24cba133c29622
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ADAMTSL1 MXRA5 RARB GALNT17 ABCA6 SEMA5B KCNJ8 MAB21L1	2.14e-06	200	187	8	fee22a6a6c7b93af204b5b56f2c34f1411500e18
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast-Smooth_Muscle-like_MyoFibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CYP1B1 PSD NT5E GAS1 FHOD3 CKM KCNMB1	2.16e-06	140	187	7	5623a0a68403fc00166b7d13d13e184a718d9bdd
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 FBXL13 CYP24A1 FHOD3 PLEKHH1 FAT2 CKMT1A	5.23e-06	160	187	7	18ae6822915d16699beb9047baeef9b006901a35
ToppCell	390C-Epithelial_cells-Epithelial-H_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	MXRA5 FBXL13 CYP24A1 FHOD3 PLEKHH1 FAT2 CKMT1A	5.23e-06	160	187	7	830f17bad94de05612fe6d53d39e42a4b3f3e2f3
ToppCell	facs-Lung-18m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TSR2 THSD7A NT5E ITPK1 FAM78A GAN AGAP2	7.78e-06	170	187	7	bda900c836e0f2c1d7b442beb50b672d025b2420
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3GL2 MAB21L2 RPH3A FAT2 NWD2 MAB21L1 CKMT1A	1.13e-05	180	187	7	d76349ecef7c5878bf215e946f032264161eb61b
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBXL3 LPIN1 DLG3 RORC FLRT3 TOP3B LRRC75A	1.17e-05	181	187	7	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	facs-Heart-RA-18m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 PFKM CKM CKMT2 RORC IGSF23	1.30e-05	184	187	7	72b42dfca7e9c0257f11d8242531e843271871a7
ToppCell	facs-Heart-RA-18m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 PFKM CKM CKMT2 RORC IGSF23	1.30e-05	184	187	7	c6f4537ae8b6e8fde1be17df14629b7b49b4997c
ToppCell	Control-Epithelial-Club\|Epithelial / Disease state, Lineage and Cell class	CYP2A6 CYP2A7 ADAMTSL1 NT5E VAT1L SEMA6D GAN	1.35e-05	185	187	7	6814b3c94c7558443c038a227b5c8563d2cfeac4
ToppCell	facs-Brain_Non-Myeloid-Cerebellum\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3GL2 MAB21L2 RPH3A FZD1 FAT2 NWD2 MAB21L1	1.35e-05	185	187	7	c083a4974590b9ed3ecafedd3e9cdebc5047fe39
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT OBSCN PFKM CKM CKMT2 RORC PGM2	1.35e-05	185	187	7	9245c322aae8bb9065d50dada198a5ee143a3444
ToppCell	COVID-19-Epithelial_cells-Airway_basal\|COVID-19 / group, cell type (main and fine annotations)	CYP24A1 FHOD3 CACHD1 ITGA3 FAT2 IGFBP2 DNAH5	1.44e-05	187	187	7	8407a82e98f56a94ea26562bcb6bbe00a8f41661
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT OBSCN FHOD3 CKM CKMT2 RORC MYO18B	1.66e-05	191	187	7	543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCell	facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT OBSCN FHOD3 CKM CKMT2 RORC MYO18B	1.66e-05	191	187	7	9d7d680da3979e256191b534ebd14c5383e0cf93
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ADAMTSL1 MXRA5 RARB KIF26B GAS1 RDH10 IGFBP2	1.66e-05	191	187	7	156b467187331ac6ca390d6ca861d9670bb7b956
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD7A GAS1 ITGA3 CR1 IGFBP2 FLRT3 FZD2	1.71e-05	192	187	7	ef0aba777072429a6ab7dcfcc305673975946580
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1B1 PSD NT5E GAS1 CKM LPIN1 KCNJ8	1.71e-05	192	187	7	93903576dddd8227328e4ced75aa7625eedb9baf
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1B1 PSD NT5E GAS1 CKM LPIN1 KCNJ8	1.77e-05	193	187	7	cfab88935abe0a15632c5eec8ff00a857ec9b3ed
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 CACNA2D1 MYOT GAS1 ASH1L CCT6A ABCA6	1.89e-05	195	187	7	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FKBP10 MXRA5 RARA NT5E PFKM AP4E1 ZNF564	2.02e-05	197	187	7	4edf043e8f586fd375f56485841fe992a18bf853
ToppCell	Tracheal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CPA6 CYP1B1 VAT1L GFRA2 FZD2 MAB21L1 WDR62	2.02e-05	197	187	7	2cb1f557ce1400398975de94638126b4522567f3
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	FKBP10 CACNA2D1 MXRA5 KIF26B APBB2 GALNT17 ABCA6	2.02e-05	197	187	7	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high\|Airway / Age, Tissue, Lineage and Cell class	CYP1B1 FKBP10 MXRA5 GAS1 RDH10 GALNT17 MAB21L1	2.02e-05	197	187	7	9a053a32ff9c3a85ef9a3382453acd619cc48546
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CYP1B1 MXRA5 FZD1 SEMA6D FLRT3 PDE7B MAB21L1	2.09e-05	198	187	7	a8c21f4db6730d0aa05b61fbe72bf9f7571a9015
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CYP1B1 MXRA5 FZD1 SEMA6D FLRT3 PDE7B MAB21L1	2.09e-05	198	187	7	8b68fc887e5ad0a59ea4d93dfd1edda67030f142
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CYP2A6 ADAMTSL1 RARB NT5E VAT1L OVOL2 DNAH5	2.09e-05	198	187	7	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	10x3'2.3-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CYP1B1 MXRA5 FZD1 SEMA6D FLRT3 PDE7B MAB21L1	2.09e-05	198	187	7	4739b2e4ab141c66772e61686b45614a1839483e
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CYP1B1 MXRA5 FZD1 SEMA6D RORB FLRT3 PDE7B	2.16e-05	199	187	7	9b2262edbdec89166d895ab97527e0ee5f9b6010
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CYP1B1 MXRA5 FZD1 SEMA6D RORB FLRT3 PDE7B	2.16e-05	199	187	7	251b3643dcd8f4645b17101bd716e66f12a20e88
ToppCell	10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MXRA5 RARB MAB21L2 FZD1 SEMA6D PDE7B MAB21L1	2.16e-05	199	187	7	6200618e029063486719479c41eaf31798bd13cf
ToppCell	10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CYP1B1 MXRA5 FZD1 SEMA6D RORB FLRT3 PDE7B	2.16e-05	199	187	7	117f4f43b6c06dda553799b1063e827bce697370
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	GAS1 RDH10 CACHD1 STAT1 FZD7 KMT2A MYBL2	2.16e-05	199	187	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RARB CYP24A1 OBSCN FHOD3 GDA FAT2 VILL	2.23e-05	200	187	7	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	droplet-Skin-nan-21m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FKBP10 NT5E GAS1 GFRA2 FZD7 VILL FZD2	2.23e-05	200	187	7	69295705fc614c2687f2b6c8e6aa0c6717841008
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma\|TCGA-Breast / Sample_Type by Project: Shred V9	CYP2A6 RPH3A MEP1A CARTPT CCT6B CKMT1A	2.70e-05	139	187	6	898322c0af83038a82fe01da99209d619c5a6156
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Mucinous_Carcinoma-1\|TCGA-Breast / Sample_Type by Project: Shred V9	CYP2A6 CYP2A7 PSD RPH3A MEP1A CARTPT	3.43e-05	145	187	6	1e52e3c615b49e7388cd58a04e74cafac9552447
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	THSD7A FHOD3 GFRA2 OVOL2 GALNT17 RORB	5.34e-05	157	187	6	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	Children_(3_yrs)-Epithelial-basal_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 CYP24A1 FHOD3 CACHD1 IGFBP2	5.34e-05	157	187	6	6ee2692f705bdd93ba523dffaf2f0cd921b47e28
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)\|Thalamus / BrainAtlas - Mouse McCarroll V32	KLHL1 VAT1L FZD1 CARTPT NWD2 MAB21L1	6.14e-05	161	187	6	0605134a342d74ae81f33700d6ddfcd6e03aeb7b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARB CD163 CARTPT GALNT17 SEMA5B PCSK9	7.04e-05	165	187	6	1b7dfa173e83aa8c46a3153a3261866c065c3b73
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RARB CD163 CARTPT GALNT17 SEMA5B PCSK9	7.04e-05	165	187	6	b4f7d33af7d053ec07b01bd67d861600a9c4822e
ToppCell	droplet-Heart-nan-24m-Hematologic-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZRANB3 PGM3 PLEKHH1 FAM78A CCT6A MYBL2	7.52e-05	167	187	6	bad33497ceeab968a7eb8a48b921c6f936390743
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CYP1B1 RDH10 OBSCN CKM CKMT2 KCNMB1	7.52e-05	167	187	6	91b14df450bfb6a2b406c88f8c75cd51eeb9e82b
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	VAT1L ADD2 FLRT3 ZNF709 IGSF23 CKMT1A	7.77e-05	168	187	6	e870d2e69316406f45112ed0bf324b24f902a99e
ToppCell	368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	VAT1L ADD2 FLRT3 ZNF709 IGSF23 CKMT1A	7.77e-05	168	187	6	403aba73a0f9ffb32252288d075fad8a588ca440
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)\|Striatum / BrainAtlas - Mouse McCarroll V32	MBD1 VARS2 SMC5 FBXL3 EIF2S3 FASTKD3	8.03e-05	169	187	6	c3bf0cb67f200d02d5a021754e9b2a68d23ea168
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)--\|Striatum / BrainAtlas - Mouse McCarroll V32	MBD1 VARS2 SMC5 FBXL3 EIF2S3 FASTKD3	8.03e-05	169	187	6	5375eb52ebadccb7bfff997a11985f23e81014d6
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Gad1Gad2.Sgol2a_(Very_small_cluster)-\|Striatum / BrainAtlas - Mouse McCarroll V32	MBD1 VARS2 SMC5 FBXL3 EIF2S3 FASTKD3	8.03e-05	169	187	6	1c132d21255f5a5174ac38db4e91927f9093418e
ToppCell	E15.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	THSD7A FHOD3 VAT1L MAB21L2 LRCH4 MAB21L1	8.85e-05	172	187	6	a8b33d8ebc56e442a2ad6ac7dafd0c887571bd95
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAT2 PLEKHH1 GMCL1 MTMR14 VILL PDE7B	9.43e-05	174	187	6	c58328c2f262506a4518f49f148e29874faf9171
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 MYOT OBSCN FHOD3 GALNT17 MYO18B	1.00e-04	176	187	6	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRPV1 RDH10 OBSCN NWD2 KCNJ8 PDE7B	1.04e-04	177	187	6	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OBSCN FHOD3 CKM CKMT2 KCNJ8 KCNMB1	1.04e-04	177	187	6	c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	OBSCN FHOD3 CKM CKMT2 KCNJ8 KCNMB1	1.04e-04	177	187	6	7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_TIP\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	CYP1B1 FKBP10 CPZ FZD7 IGFBP2 FZD2	1.07e-04	178	187	6	cda7695411655bd6d0ba69e5041ca7530a9dad3a
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FKBP10 MXRA5 OBSCN FHOD3 KCNJ8 PDE7B	1.10e-04	179	187	6	a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d
ToppCell	droplet-Liver-LIVER-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPA6 THSD7A VAT1L ADD2 FZD2 MAB21L1	1.14e-04	180	187	6	3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CYP1B1 ADAMTSL1 GAS1 CPZ GDA KCNJ8	1.14e-04	180	187	6	9adebde5f4ca6dcb90e9113622862e14298465ac
ToppCell	droplet-Liver-LIVER-30m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPA6 THSD7A VAT1L ADD2 FZD2 MAB21L1	1.14e-04	180	187	6	47e345359064dc8ceec982b062e47802e728b43f
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT OBSCN PFKM CKM CKMT2 PGM2	1.14e-04	180	187	6	cea62fc006d68c3815c88bf17ec2617d7e41c3d2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH3GL2 MAB21L2 RPH3A NWD2 MAB21L1 CKMT1A	1.14e-04	180	187	6	3d54cc767e25d91ed2203d8a03e5bf5e15f21699
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 OBSCN FHOD3 CKMT2 GALNT17 MYO18B	1.17e-04	181	187	6	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	KLHL1 CACHD1 NWD2 SEMA6D VILL CD163L1	1.17e-04	181	187	6	b9fe3833a6a56b9fbe5c257393fdbea5bf8ac4a3
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYOT PFKM CKM CKMT2 RORC PGM2	1.21e-04	182	187	6	edfc598b7199ca1d8a399b264ab863c299b1eede
ToppCell	COVID-19-Heart-EC_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	THSD7A RDH10 APBB2 ADD2 PIK3C2A PDE7B	1.24e-04	183	187	6	ff95382cfed592190d0636d2b750328471f82e0d
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FKBP10 THSD7A ESR2 APBB2 CACHD1 CKMT1A	1.28e-04	184	187	6	f506d0ee48f39d6f59f19554217dfdf0987cc405
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FKBP10 THSD7A ESR2 APBB2 CACHD1 CKMT1A	1.28e-04	184	187	6	8bcb1c4bc8ffef74338cdade926a94711de93c64
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PSD MUC5B CD163 EXO1 FIGNL1 MYBL2	1.32e-04	185	187	6	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CACNA2D1 OBSCN FHOD3 CKMT2 GALNT17 MYO18B	1.32e-04	185	187	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SH3GL2 GFRA2 GDA NWD2 RORB PDE7B	1.36e-04	186	187	6	bdbe290f81106a53c8c30a92fbb385597c62b2ac
ToppCell	droplet-Spleen-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B CACHD1 ADD2 FER1L4 EXO1 FIGNL1	1.40e-04	187	187	6	c81d11d9fdc22dc39222f62c2888025c2e8c3e65
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 CKM CKMT2 MYO18B IGSF23	1.44e-04	188	187	6	90dc0e15798d0b984518ad58c7e416e30aff687a
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	SEMA6B GFRA2 CD163 FZD1 KCNMB1 FZD2	1.44e-04	188	187	6	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	SEMA6B GFRA2 CD163 FZD1 KCNMB1 FZD2	1.44e-04	188	187	6	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 CKM CKMT2 MYO18B IGSF23	1.44e-04	188	187	6	f63dfd076ced81013918363282ae25cbbd8948ae
ToppCell	facs-Heart-LA/RA-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 CKM CKMT2 MYO18B IGSF23	1.44e-04	188	187	6	0554d542149cef654ff1e5e32dfbffd8990b52bd
ToppCell	droplet-Kidney-KIDNEY-30m-Mesenchymal-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 CACNA2D1 ADAMTSL1 ABCA6 GAN FZD2	1.48e-04	189	187	6	544d95df910f1b276995624509a7e41b219baca0
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 CKM CKMT2 MYO18B IGSF23	1.48e-04	189	187	6	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	CYP24A1 FHOD3 MUC5B CACHD1 FAT2 DNAH5	1.48e-04	189	187	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	facs-Skin-Skin_Anagen-18m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NT5E GAS1 UPF1 GFRA2 FZD7 FZD2	1.48e-04	189	187	6	d00410010283dc6191ce9857d6c7952678fed588
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN FHOD3 CKM CKMT2 MYO18B IGSF23	1.48e-04	189	187	6	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CYP1B1 RARB KIF26B GAS1 LPIN1 GALNT17	1.52e-04	190	187	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GAS1 ITGA3 CR1 IGFBP2 FLRT3 FZD2	1.52e-04	190	187	6	92710caaff05123cf8e909319d7ac441d9b31a66
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP1B1 ADAMTSL1 FBXL13 GAS1 CPZ FZD2	1.57e-04	191	187	6	b51e0f5d1b93f526160c904e9091313a5364f3a7
ToppCell	Children_(3_yrs)-Epithelial-club_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CYP2A6 CYP2A7 ADAMTSL1 RARB VAT1L DNAH5	1.57e-04	191	187	6	23776c7302cead3881b39127398f3b3e0d27885e
Drug	AC1L1YAP	ESR1 CKM CKMT2 CKMT1A	1.42e-07	7	184	4	CID000063066
Drug	lombricine	CKM CKMT2 PIK3C2A CKMT1A	5.04e-07	9	184	4	CID000159847
Drug	BIIB513	CKM CKMT2 PIK3C2A CKMT1A	5.04e-07	9	184	4	CID006918374
Drug	ONO-3144	CKM CKMT2 PIK3C2A CKMT1A	8.35e-07	10	184	4	CID000166446
Drug	AC1L4VLE	CKM CKMT2 PIK3C2A CKMT1A	1.30e-06	11	184	4	CID000193097
Drug	stannous pyrophosphate	CKM CKMT2 PIK3C2A CKMT1A	1.30e-06	11	184	4	CID000066379
Drug	AC1L1KIN	CYP1B1 CYP2A6 CYP2A7 CYP2C8 ESR1 ESR2 CYP24A1 MYBL2	1.54e-06	100	184	8	CID000005516
Drug	Triiodothyronine	FKBP10 RARA RARB NT5E ESR1 CYP24A1 HMGCS1 STAT1 ADD2 ITPK1 FZD7 IGFBP2 TMEM44 ZC3H7B PCSK9 MYBL2	1.80e-06	477	184	16	ctd:D014284
Drug	N-desmethyl-tamoxifen-hydrochloride	PRKD2 CYP1B1 CYP2A6 CYP2C8 ESR1 ESR2	3.84e-06	52	184	6	CID000035887
Drug	Dextromethorphan hydrobromide monohydrate [6700-34-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A	PNPLA2 TRPV1 TUT4 RARA ZNF862 APBB2 FZD1 AP4E1 SYCP2 ZC3H7B	3.87e-06	192	184	10	5401_DN
Drug	ATP gamma-(N-(2-chloroethyl)-N-methyl)amide	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000174813
Drug	epoxycreatine	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000194341
Drug	gamma-benzylamide ATP	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000194049
Drug	vitamin K1 diacetate	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID006441272
Drug	ATP gamma-p-azidoanilide	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID003035480
Drug	homocyclocreatine	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000128636
Drug	N-2-hydroxyethyl-N-methyl-gamma-amide ATP	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000195952
Drug	steroid U	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000133659
Drug	gamma-anilide ATP	CKM CKMT2 CKMT1A	5.13e-06	5	184	3	CID000193883
Drug	hippuryl-L-lysine	CPA6 CKM CKMT2 CKMT1A	9.05e-06	17	184	4	CID000098208
Drug	2,6-dimethylnaphthalene	CYP2A6 ESR1 ESR2	1.02e-05	6	184	3	ctd:C028519
Drug	phosphocyclocreatine	CKM CKMT2 CKMT1A	1.02e-05	6	184	3	CID000124896
Drug	Creatine	CKM CKMT2 CKMT1A	1.02e-05	6	184	3	DB00148
Drug	CoADP	CKM CKMT2 CKMT1A	1.02e-05	6	184	3	CID000194171
Drug	PTMSA	CKM CKMT2 CKMT1A	1.02e-05	6	184	3	CID000006934
Drug	hexahydro-4-methyl phthalic anhydride	CKM CKMT2 CKMT1A	1.02e-05	6	184	3	CID000086876
Drug	beta-NADP	CYP1B1 CYP2A6 CYP2A7 CYP2C8 SPR NT5E ACLY CYP24A1 RDH10 RDH13 HMGCS1 VAT1L PFKM PGM3 PGM2	1.14e-05	490	184	15	CID000000929
Drug	Ro 41-5253	RARA RARB ANXA4 ESR1 STAT1	1.15e-05	37	184	5	CID005312120
Drug	gemcadiol	CKM CKMT2 CKMT1A	1.77e-05	7	184	3	CID000037147
Drug	2-nitrobenzenesulphonyl fluoride	CKM CKMT2 CKMT1A	1.77e-05	7	184	3	CID000097375
Drug	1-carboxymethyl-2-iminohexahydropyrimidine	CKM CKMT2 CKMT1A	1.77e-05	7	184	3	CID000193725
Drug	Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A	FKBP10 PNPLA2 MBD1 APBB2 HMGCS1 ITPK1 LPIN1 DLG3 ZC3H7B	1.80e-05	182	184	9	7422_UP
Drug	P-31	CACNA2D1 CKM CKMT2 CKMT1A	1.81e-05	20	184	4	CID000017959
Drug	phosphocreatinine	CKM CKMT2 PIK3C2A CKMT1A	2.22e-05	21	184	4	CID000071214
Drug	carteolol	CYP1B1 CYP2A6 CACNA2D1 CYP2A7 CYP2C8 CYP24A1	2.58e-05	72	184	6	CID000002583
Drug	fenarimol	RARB ESR1 ESR2 HMGCS1 LRRC75A	2.75e-05	44	184	5	ctd:C033789
Drug	dihydrogenistein	ESR1 ESR2 CYP24A1	2.82e-05	8	184	3	CID009838356
Drug	Rh(H2O)4PP	CKM CKMT2 CKMT1A	2.82e-05	8	184	3	CID000194736
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	CYP1B1 FKBP10 ESR1 CYP24A1 HMGCS1 STAT1 VILL MAPK7 AGAP2	2.86e-05	193	184	9	3857_UP
Drug	DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A	TRPV1 RARA ZNF862 MBD1 ASH1L CR1 FZD7 RBM19 CCT6B	2.98e-05	194	184	9	7543_UP
Drug	TMPG	CKM CKMT2 PIK3C2A CKMT1A	3.24e-05	23	184	4	CID000130084
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A	TRPV1 RARA ZNF862 ESR1 APBB2 ITPK1 FZD1 SEMA6D TOP3B	3.36e-05	197	184	9	6050_DN
Drug	tolbutamide	CYP1B1 CYP2A6 CYP2A7 CYP2C8 CYP24A1 PFKM KCNJ6 KCNJ8 PGM2	3.50e-05	198	184	9	CID000005505
Drug	Althiazide [5588-16-9]; Up 200; 10.4uM; PC3; HT_HG-U133A	TUT4 ZNF862 APBB2 RPH3A RLN2 SYCP2 KMT2A GAN PDE7B	3.50e-05	198	184	9	4491_UP
Drug	oxaloacetate	SPR ACLY PFKM PGM3 MEP1A CKM CKMT2 PGM2 CKMT1A	3.50e-05	198	184	9	CID000000970
Drug	celestolide	ESR1 ESR2 AGAP2	4.21e-05	9	184	3	CID000061585
Drug	OR-486	CYP1B1 ESR1 ESR2 SLC25A19	5.37e-05	26	184	4	CID001810907
Drug	naphthalene epoxide	CYP1B1 CYP2A6 CYP2A7 CYP2C8 RBM19	5.67e-05	51	184	5	CID000108063
Drug	pyridinophane cryptand	CKM CKMT2 CKMT1A	5.98e-05	10	184	3	CID006454246
Drug	cyanofenphos	NT5E ESR1 ESR2	5.98e-05	10	184	3	CID000025669
Drug	Indans	TRPV1 ESR1 ESR2	5.98e-05	10	184	3	ctd:D007189
Drug	BP-9,10-oxide	CYP1B1 CYP2A6 CYP2A7 CYP2C8	6.26e-05	27	184	4	CID000037456
Drug	Brn 4136738	CYP1B1 CYP2A6 CYP2A7 CYP2C8	6.26e-05	27	184	4	CID000050331
Drug	C14845	CYP1B1 CYP2A6 CYP2A7 CYP2C8	6.26e-05	27	184	4	CID011954064
Drug	5-octylphenol	ESR1 ESR2	6.50e-05	2	184	2	ctd:C113977
Drug	tetradifon	ESR1 ESR2	6.50e-05	2	184	2	ctd:C005807
Drug	etocrylene	ESR1 ESR2	6.50e-05	2	184	2	CID000243274
Drug	Ro 8-8717	RARA RARB	6.50e-05	2	184	2	CID006438148
Drug	Raloxifene	ESR1 ESR2	6.50e-05	2	184	2	DB00481
Drug	Brn 0187733	ESR1 ESR2	6.50e-05	2	184	2	CID000160446
Drug	PHTPP	ESR1 ESR2	6.50e-05	2	184	2	CID011201035
Drug	butolame	ESR1 ESR2	6.50e-05	2	184	2	CID000197608
Drug	LY 326315	ESR1 ESR2	6.50e-05	2	184	2	CID009803972
Drug	JK 1624F2-1	ESR1 ESR2	6.50e-05	2	184	2	ctd:C113642
Drug	octocrylene	ESR1 ESR2	6.50e-05	2	184	2	ctd:C088673
Drug	O-desmethylangolensin	ESR1 ESR2	6.50e-05	2	184	2	ctd:C050052
Drug	CHEMBL397775	ESR1 ESR2	6.50e-05	2	184	2	CID010214678
Drug	Cyclohexanone, 3b	ESR1 ESR2	6.50e-05	2	184	2	CID011370317
Drug	CHEMBL234633	ESR1 ESR2	6.50e-05	2	184	2	CID010192968
Drug	SureCN14514707	ESR1 ESR2	6.50e-05	2	184	2	CID010192967
Drug	(4R)-6-(ethoxymethyl)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	6.50e-05	2	184	2	CID011175195
Drug	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	6.50e-05	2	184	2	DB08020
Drug	ethyl cinnamate	ESR1 ESR2	6.50e-05	2	184	2	ctd:C451418
Drug	(4R)-4-(4-hydroxyphenyl)-6-methylol-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	6.50e-05	2	184	2	CID011174414
Drug	phytoene	ESR1 ESR2	6.50e-05	2	184	2	ctd:C100185
Drug	CHEMBL48352	ESR1 ESR2	6.50e-05	2	184	2	CID011522286
Drug	bromophos	ESR1 ESR2	6.50e-05	2	184	2	ctd:C100092
Drug	SureCN14514705	ESR1 ESR2	6.50e-05	2	184	2	CID010125414
Drug	3,4-dihydroxybenzaldoxime	ESR1 ESR2	6.50e-05	2	184	2	ctd:C053286
Drug	Tamoxifen	ESR1 ESR2	6.50e-05	2	184	2	DB00675
Drug	SureCN14514737	ESR1 ESR2	6.50e-05	2	184	2	CID010149292
Drug	di-(5-methylhexyl)phthalate	ESR1 ESR2	6.50e-05	2	184	2	ctd:C042791
Drug	phytofluene	ESR1 ESR2	6.50e-05	2	184	2	ctd:C003140
Drug	1x7e	ESR1 ESR2	6.50e-05	2	184	2	CID000656953
Drug	salicylaldoxime	ESR1 ESR2	6.50e-05	2	184	2	ctd:C005704
Drug	Pyrazolo[1,5-a]pyrimidine, 12d	ESR1 ESR2	6.50e-05	2	184	2	CID016103245
Drug	Pyrazolo[1,5-a]pyrimidine, 12c	ESR1 ESR2	6.50e-05	2	184	2	CID016103238
Drug	SureCN3587271	ESR1 ESR2	6.50e-05	2	184	2	CID011208678
Drug	CNP-amino	ESR1 ESR2	6.50e-05	2	184	2	CID000033473
Drug	ERB 041	ESR1 ESR2	6.50e-05	2	184	2	ctd:C478102
Drug	(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	6.50e-05	2	184	2	DB07933
Drug	4-(4-hydroxyphenyl)-6-methyl-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol	ESR1 ESR2	6.50e-05	2	184	2	CID010125512
Drug	2-phenylbenzofuran	ESR1 ESR2	6.50e-05	2	184	2	CID003517936
Drug	steroid C	ESR1 ESR2	6.50e-05	2	184	2	CID000454473
Drug	2z4b	ESR1 ESR2	6.50e-05	2	184	2	CID011197931
Drug	dehydroestrone	ESR1 ESR2	6.50e-05	2	184	2	CID000102225
Drug	(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL	ESR1 ESR2	6.50e-05	2	184	2	DB07638
Drug	prolame	ESR1 ESR2	6.50e-05	2	184	2	CID000127441
Drug	benzohydrol	ESR1 ESR2	6.50e-05	2	184	2	ctd:C020225
Drug	parthenocissin A	ESR1 ESR2	6.50e-05	2	184	2	ctd:C549189
Disease	MEHMO syndrome (implicated_via_orthology)	EIF2S3B EIF2S3	3.74e-05	2	181	2	DOID:0060801 (implicated_via_orthology)
Disease	Usher syndrome type 3B (implicated_via_orthology)	HARS2 HARS1	3.74e-05	2	181	2	DOID:0110842 (implicated_via_orthology)
Disease	prostate carcinoma in situ (implicated_via_orthology)	ESR1 ESR2	3.74e-05	2	181	2	DOID:8634 (implicated_via_orthology)
Disease	Charcot-Marie-Tooth disease, axonal type 2W (implicated_via_orthology)	HARS2 HARS1	3.74e-05	2	181	2	DOID:0110162 (implicated_via_orthology)
Disease	Liver carcinoma	CYP2C8 RARA KMT2B ACLY ANXA4 ESR1 STAT1 CD163 EXO1 KMT2A WDR62 MYBL2	7.52e-05	507	181	12	C2239176
Disease	Intellectual Disability	SPR ASH1L TRRAP FBXL3 PGM3 CSDE1 AP4E1 EIF2S3 MAB21L1 DYNC1H1 WDR62	1.07e-04	447	181	11	C3714756
Disease	peritonitis (implicated_via_orthology)	ESR1 ESR2	1.12e-04	3	181	2	DOID:8283 (implicated_via_orthology)
Disease	Neuralgia-Neuritis, Sciatic Nerve	RARA RARB	2.23e-04	4	181	2	C0751924
Disease	Sciatic Nerve Palsy	RARA RARB	2.23e-04	4	181	2	C0751925
Disease	Sciatic Neuropathy	RARA RARB	2.23e-04	4	181	2	C0149940
Disease	Perrault syndrome (implicated_via_orthology)	HARS2 HARS1	2.23e-04	4	181	2	DOID:0050857 (implicated_via_orthology)
Disease	sensory peripheral neuropathy (implicated_via_orthology)	HARS2 HARS1	2.23e-04	4	181	2	DOID:2491 (implicated_via_orthology)
Disease	Lesion of Sciatic Nerve	RARA RARB	2.23e-04	4	181	2	C0154748
Disease	Sciatic Neuritis	RARA RARB	2.23e-04	4	181	2	C0242013
Disease	Obesity	CYP1B1 TRPV1 ACLY ESR1 CD163 CARTPT IGFBP2	2.86e-04	205	181	7	C0028754
Disease	creatine kinase m-type:creatine kinase b-type heterodimer measurement	CD163 CKM	3.70e-04	5	181	2	EFO_0020292
Disease	kallikrein-7 measurement	CD163 CD163L1	3.70e-04	5	181	2	EFO_0008195
Disease	Cardiac Arrhythmia	CACNA2D1 ESR2 KCNJ8	4.73e-04	25	181	3	C0003811
Disease	hypopituitarism (implicated_via_orthology)	EIF2S3B EIF2S3	5.52e-04	6	181	2	DOID:9406 (implicated_via_orthology)
Disease	childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement	CYP1B1 KLHL1	5.52e-04	6	181	2	EFO_0004847, EFO_0008361, MONDO_0005405
Disease	breast carcinoma (is_marker_for)	ESR1 CYP24A1 FZD1 FZD2	7.34e-04	66	181	4	DOID:3459 (is_marker_for)
Disease	Carcinoma, Granular Cell	CYP2A6 RARB ESR1 ESR2 KMT2A	7.61e-04	116	181	5	C0205644
Disease	Adenocarcinoma, Tubular	CYP2A6 RARB ESR1 ESR2 KMT2A	7.61e-04	116	181	5	C0205645
Disease	Adenocarcinoma, Oxyphilic	CYP2A6 RARB ESR1 ESR2 KMT2A	7.61e-04	116	181	5	C0205642
Disease	Carcinoma, Cribriform	CYP2A6 RARB ESR1 ESR2 KMT2A	7.61e-04	116	181	5	C0205643
Disease	Adenocarcinoma, Basal Cell	CYP2A6 RARB ESR1 ESR2 KMT2A	7.61e-04	116	181	5	C0205641
Disease	Adenocarcinoma	CYP2A6 RARB ESR1 ESR2 KMT2A	7.61e-04	116	181	5	C0001418
Disease	abnormal vaginal discharge smell	CYP24A1 KCNJ6	7.70e-04	7	181	2	EFO_0009408
Disease	Microcephaly	TRRAP EIF2S3 DYNC1H1 WDR62	7.77e-04	67	181	4	C0025958
Disease	Alzheimer disease, educational attainment	RARB PSD ESR2 ARFGEF2 CR1 ARL6IP4 SEMA6D	8.66e-04	247	181	7	EFO_0011015, MONDO_0004975
Disease	gestational age, parental genotype effect measurement	CACNA2D1 VARS2 ASB7	1.29e-03	35	181	3	EFO_0005112, EFO_0005939
Disease	sensory perception of sound	CPA6 CYP2A6	1.31e-03	9	181	2	GO_0007605
Disease	leukodystrophy (implicated_via_orthology)	EIF2S3B EIF2S3	1.31e-03	9	181	2	DOID:10579 (implicated_via_orthology)
Disease	migraine (is_implicated_in)	TRPV1 ESR1	1.31e-03	9	181	2	DOID:6364 (is_implicated_in)
Disease	response to selective serotonin reuptake inhibitor	CYP2A7 KIF26B ARFGEF2 SEMA6D	1.65e-03	82	181	4	EFO_0005658
Disease	Allodynia	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C0458247
Disease	Mechanical Allodynia	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C2936719
Disease	Hyperalgesia, Secondary	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C0751212
Disease	Hyperalgesia, Primary	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C0751211
Disease	Hyperalgesia, Thermal	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C0751214
Disease	Tactile Allodynia	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C0751213
Disease	Hyperalgesia	CACNA2D1 TRPV1 CARTPT MAPK7	1.80e-03	84	181	4	C0020429
Disease	Other specified cardiac arrhythmias	CACNA2D1 KCNJ8	1.98e-03	11	181	2	C0348626
Disease	Prostatic Intraepithelial Neoplasias	ESR1 ESR2	1.98e-03	11	181	2	C0282612
Disease	Nodal rhythm disorder	CACNA2D1 KCNJ8	1.98e-03	11	181	2	C0264893
Disease	Ectopic rhythm	CACNA2D1 KCNJ8	1.98e-03	11	181	2	C1399226
Disease	Shortened QT interval	CACNA2D1 KCNJ8	1.98e-03	11	181	2	C0151879
Disease	CARDIAC CONDUCTION DEFECT, NONSPECIFIC (disorder)	CACNA2D1 KCNJ8	1.98e-03	11	181	2	C2748542
Disease	Combined immunodeficiency	STAT1 PGM3 PNP	2.04e-03	41	181	3	C0494261
Disease	nicotine metabolite ratio	CYP2A6 CYP2A7	2.37e-03	12	181	2	EFO_0007794
Disease	lymphangioleiomyomatosis (is_marker_for)	ESR1 STAT1	2.37e-03	12	181	2	DOID:3319 (is_marker_for)
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A MYBL2	2.37e-03	12	181	2	DOID:9119 (implicated_via_orthology)
Disease	nasopharyngeal neoplasm	CPA6 CYP2A6 ADD2 GALNT17 KMT2A	2.44e-03	151	181	5	EFO_0004252
Disease	concentration of large LDL particles measurement	ABCA6 PCSK9 IGSF23	2.50e-03	44	181	3	EFO_0022160
Disease	cholesterol in medium VLDL measurement	ABCA6 PCSK9 IGSF23	2.50e-03	44	181	3	EFO_0022225
Disease	kynurenic acid measurement	THSD7A SEMA6D	2.79e-03	13	181	2	EFO_0010506
Disease	taurolithocholate 3-sulfate measurement	RARB ESR1	2.79e-03	13	181	2	EFO_0021036
Disease	Brugada Syndrome 1	CACNA2D1 KCNJ8	2.79e-03	13	181	2	C4551804
Disease	prostate cancer (is_marker_for)	KMT2B ESR1 KMT2A MAPK7 AGAP2	2.81e-03	156	181	5	DOID:10283 (is_marker_for)
Disease	dystonia (is_implicated_in)	KMT2B SPR	3.24e-03	14	181	2	DOID:543 (is_implicated_in)
Disease	Malformations of Cortical Development	DYNC1H1 WDR62	3.24e-03	14	181	2	C1955869
Disease	phoneme awareness	ARFGEF2 KCNJ6	3.24e-03	14	181	2	EFO_0021812
Disease	Cortical Dysplasia	DYNC1H1 WDR62	3.24e-03	14	181	2	C0431380
Disease	apolipoprotein B to apolipoprotein A1 ratio	ABCA6 PCSK9 IGSF23	3.40e-03	49	181	3	EFO_0021897
Disease	L2 Acute Lymphoblastic Leukemia	CYP1B1 CYP2C8 KMT2A	3.60e-03	50	181	3	C0023453
Disease	Sinus Node Dysfunction (disorder)	CACNA2D1 KCNJ8	3.73e-03	15	181	2	C0428908
Disease	total lipids in medium LDL	ABCA6 PCSK9 IGSF23	4.02e-03	52	181	3	EFO_0022180
Disease	Childhood Acute Lymphoblastic Leukemia	CYP1B1 CYP2C8 KMT2A	4.02e-03	52	181	3	C0023452
Disease	Colorectal Carcinoma	CYP1B1 CYP2A6 MYOT RARB ESR2 OBSCN LPIN1 GMCL2 ABCA6 EXO1 DLG3	4.21e-03	702	181	11	C0009402
Disease	intraocular pressure measurement	PNPLA2 MXRA5 RARB THSD7A KBTBD7 ABCA6 OR4A5 KMT2A PDE7B	4.35e-03	509	181	9	EFO_0004695
Disease	Peripheral Nervous System Diseases	CYP2C8 MYOT GAN	4.48e-03	54	181	3	C4721453
Disease	blood phosphate measurement	ADAMTSL1 RARB ESR1 CYP24A1 PDE7B	4.48e-03	174	181	5	EFO_0010972
Disease	response to homoharringtonine, cytotoxicity measurement	CPA6 CYP2A6	4.79e-03	17	181	2	EFO_0006952, EFO_0006996
Disease	Uterine leiomyoma, estrogen-receptor positive breast cancer	ESR1 EXO1	5.37e-03	18	181	2	EFO_1000649, HP_0000131
Disease	lysophosphatidylcholine 22:6 measurement	CACNA2D1 FZD7	5.37e-03	18	181	2	EFO_0010365
Disease	response to efavirenz, virologic response measurement	MBD1 LINC00299 PIK3C2A	5.47e-03	58	181	3	EFO_0006904, EFO_0006906
Disease	creatine kinase measurement	CD163 CKM CD163L1	5.74e-03	59	181	3	EFO_0004534
Disease	Usual Interstitial Pneumonia	ESR1 MUC5B	5.97e-03	19	181	2	C4721509
Disease	Hamman-Rich Disease	ESR1 MUC5B	5.97e-03	19	181	2	C4721508
Disease	caffeine metabolite measurement	CYP2A6 CYP2A7	5.97e-03	19	181	2	EFO_0007872

Protein segments in the cluster

Peptide	Gene	Start	Entry
AKRRNMERLTLACGG	CCT6A	316	P40227
MVQREKARDNFEGGC	LINC00299	1	Q6ZSB3
LEELNVFRGKCGMLF	BEST2	211	Q8NFU1
DCANGIGALKLREME	PGM3	211	O95394
RKGCVDDCLNRMIFA	ASH1L	2106	Q9NR48
RDKRLRGCIGTFSAM	AMMECR1L	146	Q6DCA0
ECRVRFLSFMGVGKD	APBB2	651	Q92870
CRMFLQRGADTNLGR	ASB7	196	Q9H672
VGGMRRIEGNLDTFC	ANTXRL	436	A6NF34
KRNCFGEGLARMELF	CYP2A6	436	P11509
DMGARGAAACDLVQR	ALDH16A1	341	Q8IZ83
GEIFMLKRCGNGVVE	ADAM21	401	Q9UKJ8
LRCISEMNRLFSGKG	FBXW10	231	Q5XX13
RGMAIKDLNAELFDC	FLRT3	341	Q9NZU0
DRKVIMSNGRLKCAG	ABCA6	681	Q8N139
IGDGKGLDMARRCSV	ARFGEF2	601	Q9Y6D5
DGGNKIRCFIMEDRG	CACHD1	831	Q5VU97
GKRICAGEGLARMEL	CYP2C8	431	P10632
DLGFRMLNCGRTDLV	BTBD11	571	A6QL63
VVGDARARALCADMK	AGAP2	526	Q99490
MRDGFGFIKCVDRDV	CSDE1	356	O75534
RRAMKGAGTDEGCLI	ANXA4	96	P09525
GGTNRCMGRVELKIQ	CD163L1	266	Q9NR16
MKCLGKRRGQAAAFL	CPA6	1	Q8N4T0
RKALCDRDVGVMAAS	AP4E1	211	Q9UPM8
EGNSMRCGRKLAKDG	GMCL1	391	Q96IK5
LGQAKMGFCTDREDI	HMGCS1	51	Q01581
VMRLADGKNIGACSL	NWD2	1601	Q9ULI1
GLVCRNREQVGKFKM	MUC5B	2941	Q9HC84
GLVCRNREQVGKFKM	MUC5B	3641	Q9HC84
FCRKTGLRVMGIVEN	NUBP2	176	Q9Y5Y2
SAGVERLLLGNKCDM	RAB13	111	P51153
VKQALKCNREYMGGR	RBM19	346	Q9Y4C8
EGCKGFFRRSIQKNM	RARA	106	P10276
EGCKGFFRRSIQKNM	RARB	106	P10826
GRELVRAQIAICGMS	RLN2	36	P04090
VMAQKRGETRALCLG	KCNMB1	6	Q16558
RKNVESFLEACRKMG	LRCH4	601	O75427
NENCELKIGDFGMAR	MAPK7	191	Q13164
LGFGICRGIDMEKRL	NOL9	606	Q5SY16
EMCKQGYRDGLRFLQ	PNPLA2	236	Q96AD5
GEGEKMVRALFAVAR	FIGNL1	476	Q6PIW4
KNARAAVAGEDGRMI	HNRNPCL1	61	O60812
SEMKGAVGRVLTRNC	OR10W1	286	Q8NGF6
AFAELCRKRGMEVVQ	ITPK1	26	Q13572
VRNGKLCFMFRVGDL	KCNJ8	201	Q15842
EVGMVKCGSRRERCG	ESR2	211	Q92731
KNARAAVAGEDGRMI	HNRNPCL2	61	B2RXH8
RAMGRLKIDFGEAAR	GNAI3	86	P08754
GGFTLEDICMLRRKD	MTMR14	421	Q8NCE2
GKLCLMFRVGDLRNS	KCNJ6	216	P48051
KNARAAVAGEDGRMI	HNRNPCL3	61	B7ZW38
EGDALGAMEKLCRQL	LRRC75A	126	Q8NAA5
QRRRGGASKEAMCFN	KIF26B	2001	Q2KJY2
ERGRDCGKIQSLMLT	FER1L4	691	A9Z1Z3
REVLCKQRMADGSFL	ADAMTSL1	751	Q8N6G6
REQRMFKRVGCGECA	MBD1	166	Q9UIS9
RGERMEAQGGKLVCR	PCSK9	496	Q8NBP7
DRNQGKCVEGMVEIF	ESR1	411	P03372
KVMARDGGGRVAFCT	FAT2	2556	Q9NYQ8
LQALVMGEGTCEKRR	IGFBP2	121	P18065
GSEDQRRMVGKCYVR	ITGA3	151	P26006
RRMVGKCYVRGNDLE	ITGA3	156	P26006
GEVMGALRKGLDRCR	OR2V1	296	Q8NHB1
IFKCLSTGRDRGMVE	PIK3C2A	1171	O00443
DSGCVLGMRKRALVF	PFKM	706	P08237
AKCVCMLGDIRLRGQ	PDE7B	21	Q9NP56
EYCDGGDLMKRINRQ	NEK5	81	Q6P3R8
LQLGRTMCGKFEDDI	CST9LP1	91	Q5W188
RARQGCEALMNKFGF	FZD2	116	Q14332
EGNKEELRKCFGARM	PGM2	41	Q96G03
ELRKCFGARMEFGTA	PGM2	46	Q96G03
AAIFKVGDDCRQDML	PI4KA	1846	P42356
GEMLFGLVRQGLKCD	PRKD2	156	Q9BZL6
EGASRMECQLKRGSV	LPIN1	111	Q14693
RLELEGRGVVCMSFF	MIGA2	416	Q7L4E1
KENMARLCFGAELGN	GAS1	236	P54826
KNARAAVAGEDGRMI	HNRNPCL4	61	P0DMR1
GRGLFCKRNIDAGEM	KMT2B	2586	Q9UMN6
RLLCREGMDVAYLNG	KBTBD7	421	Q8WVZ9
CDLCGKGFRLQRMLN	OVOL2	121	Q9BRP0
RDRDSGENGKMICSI	PCDHB15	371	Q9Y5E8
QGFRLRMGCEIVIAT	DDX23	511	Q9BUQ8
FKEFGKNREVMGLCR	ATXN7	116	O15265
RGGNIILACRDMEKC	RDH13	61	Q8NBN7
RVGFEGMSDLKCVQD	MIB1	206	Q86YT6
RAGKTMAIAAQGACR	OBSCN	2206	Q5VST9
RLMQGDEICLRYKGD	UPF1	366	Q92900
CERARQGCEALMNKF	FZD1	191	Q9UP38
RARQGCEALMNKFGF	FZD7	126	O75084
MVEFLCERGADVNRG	HECTD1	411	Q9ULT8
MDQGLQGACMGERRR	FKBP10	326	Q96AY3
GMGEKLFIRRLSCEQ	IGSF23	91	A1L1A6
MDRSENRCGGNFLKR	CPZ	426	Q66K79
GVGKRMCIGRRLAEL	CYP24A1	456	Q07973
KSCDDFMGQLLNGRV	CR1	356	P17927
KSCDDFMGQLLNGRV	CR1	806	P17927
RGSGNMEEECEKFLR	GFRA2	326	O00451
RANCNKIIMLFTDGG	CACNA2D1	351	P54289
QVNTEFIGLRRCLMG	DEFB129	16	Q9H1M3
FVEFVKMCGGRLSQL	FBXL3	376	Q9UKT7
KRNCFGEGLARMELF	CYP2A7	436	P20853
ERRFGAVACGVAMEL	GAN	456	Q9H2C0
GQCGDILTNKRFMLD	FHOD3	666	Q2V2M9
VDCYLRLGAMARDKG	CTR9	531	Q6PD62
MNKGTGRCLEVENRG	GALNT17	561	Q6IS24
ATRGDCLAFQMRAGL	ARL6IP4	221	Q66PJ3
AAMDGRLGVNDCVLR	DLG3	171	Q92796
CVRIGDMGLKQFLDG	FBXL13	461	Q8NEE6
EAENRLLMGGCRNKC	MAB21L2	236	Q9Y586
VQGAFLRFMACLLKG	DENND4B	566	O75064
RRSGCKNEKIAFIMD	DYNC1H1	2981	Q14204
GQRAFVGKVCMDLND	GDA	161	Q9Y2T3
RGLFCKRNIDAGEMV	KMT2A	3841	Q03164
MCDAGEQCAVRKGAR	CARTPT	81	Q16568
MIFSVGKRRCIGEEL	CYP1B1	461	Q16678
TLCRADRMVGQILGA	EIF2S3B	346	Q2VIR3
LTRGGNMCSGRIEIK	CD163	161	Q86VB7
KLADFGMTRRVGCRV	SBK1	191	Q52WX2
MASVRIREAKEGDCG	SAT2	1	Q96F10
VNDRRILDGMFAICG	HARS1	211	P12081
GRLVFGFLNGRACVM	PNP	66	P00491
MQFGCFVQLEGLRKR	DHX8	276	Q14562
CSDQMDFRGLGRIFK	DNAH5	2006	Q8TE73
RLLCREGMDVAYLNG	KBTBD6	421	Q86V97
GGNMKRVFERFCRGL	CKMT1A	276	P12532
FLRRKMGLDPACQVD	PCGF6	291	Q9BYE7
GVRRGRVCFEMKINE	HNRNPUL1	251	Q9BUJ2
KGGNMKRVFERFCRG	CKMT2	276	P17540
GGAEVFLLVVMACDR	OR4A5	106	Q8NH83
FVRCQEMGARAAKAV	VARS2	481	Q5ST30
AKRRNMERLSLACGG	CCT6B	316	Q92526
MRKNVAGDGVNRCIL	RPH3A	86	Q9Y2J0
KVNDRRIVDGMFAVC	HARS2	211	P49590
GCIMGFISKERERAL	STAT1	576	P42224
KRMTCGDFIGNLEGL	PSD	671	A5PKW4
GNGIKTRMLDCVRSD	THSD7A	1241	Q9UPZ6
MGCIQSIGGKARVFR	FAM78A	21	Q5JUQ0
EKGGNMKEVFRRFCV	CKM	241	P06732
EAENRLQMGGCRKKC	MAB21L1	236	Q13394
GRELVRAQIAICGMS	RLN1	36	P04808
VACGGTRDQLFMQEK	MYBL2	666	P10244
VAECQNRLRKGGMEV	FASTKD3	201	Q14CZ7
NRLRKGGMEVRNLCI	FASTKD3	206	Q14CZ7
EGNSMRCGRKLAKDG	GMCL2	391	Q8NEA9
FEKANICGMIQGTRD	MEP1A	271	Q16819
VDTGMFRGCRIRKEI	RDH10	246	Q8IZV5
DQARLGMCRQLGDVF	EXO1	196	Q9UQ84
DGLIGVAFVDMLRNC	ACLY	1026	P53396
RCMGGVARLFTKVQQ	NT5E	56	P21589
ADSLNLAKGERLMRC	ADD2	121	P35612
CRKGDIGQEMYIIRE	CNGA4	376	Q8IV77
CGRKNTARMENFAPE	RIOK3	171	O14730
LNMVKFLQVEGRGCD	TOP3B	96	O95985
AIVRGKEMIRIGDCA	TNRC18	2811	O15417
DVMRETFRNLACVGK	ZNF564	31	Q8TBZ8
CRMKGKQEGECRNFV	SEMA6B	116	Q9H3T3
QRGDGAALREMASCI	TSR2	101	Q969E8
CLALGMSRDAVKFGR	RORC	91	P51449
CMRKAFRSGKLLQVG	TRPV1	716	Q8NER1
LTGLDAGCMAARRKE	SLC26A1	561	Q9H2B4
AMLKFGRELGDDCNF	SH3GL2	96	Q99962
CAGKAARDMLFQVLA	SPR	171	P35270
CRIFLNLVNGMLGDK	SYCP2	261	Q9BX26
RCITKLENMGFRVGQ	TRAPPC6B	31	Q86SZ2
CLALGMSRDAVKFGR	RORB	81	Q92753
AAQRQVLGTEMCRGK	TMEM44	241	Q2T9K0
VRVLIVAGRKVFMCG	SEMA5B	186	Q9P283
KACGLNFIDLMVRQG	VAT1L	76	Q9HCJ6
GLCRLATREKANMEA	TTC21A	1131	Q8NDW8
FGGCRDDFMLVIRSI	PLEKHH1	1276	Q9ULM0
MVERLCERKEGSQFG	ZNF709	66	Q8N972
FGKGCNGDQREMARV	VILL	551	O15195
AGACKVGRKQFMRFE	MYO18B	836	Q8IUG5
MLSCRGGLVEKFQEV	ZNF862	701	O60290
IKFAGNRDIQMISCG	WDR62	586	O43379
RISVGGNMERSCGKL	UGT2A3	171	Q6UWM9
GLLQEKMGFCEQRRK	TTC16	406	Q8NEE8
LSCRKAGSIMREGRD	WDR3	266	Q9UNX4
GFFVKRGCSRGMVEI	SMC5	111	Q8IY18
ARICKNDMGGSQRVL	SEMA6D	256	Q8NFY4
LELVRVCGGGMQRDK	SMIM45	66	A0A590UK83
RKSGLLCRVSAGNDM	TUT4	461	Q5TAX3
FGQVRRYKGLMDCAK	SLC25A19	256	Q9HC21
LQEAGEACMRKFLEG	TRRAP	1401	Q9Y4A5
GRVQAEELGRAFRCM	PPIP5K1	531	Q6PFW1
MECGKAFNRRSGLTR	ZNF805	486	Q5CZA5
IFALKRNGRCMVADE	ZRANB3	46	Q5FWF4
RRAAQMCGLKEVGED	TTLL13	101	A6NNM8
MGEFRLCDRLQKGKA	ZC3H7B	886	Q9UGR2
TLCRADRMVGQVLGA	EIF2S3	346	P41091
GIRAFADAQGCIELM	KLHL1	316	Q9NR64
LVCMARNEGGEARLI	MXRA5	2516	Q9NR99
IDEGRFCRMDFKVSG	MYOT	261	Q9UBF9